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ABSTRACT
A mouse lymphatic endothelial cell (SVEC4-10) model and a human intestinal cell
(C2BBe1) model in vitro were developed and capable to be used to study antioxidant activity,
hypocholesterolemic capability and digestibility of γ-oryzanol. The critical and vital parameters
in developing these cell models were the emulsion preparation of hydrophobic compounds for
cell models, the consistent management of cell culture, and the selection of cell viability
detection methods compatible with the cell lines and the test substances. The results showed that,
in some situations, γ-oryzanol could present a more effective antioxidant activity than αtocopherol, in terms of reducing tert-butyl hydroperoxide promoted oxidative damage on cellular
mitochondrial activity. After 1-hour oxidation, cell viability was 81.8% when incubated with γoryzanol, compared to 54.5% with the control and 74.6% with α-tocopherol. The three major
components of γ-oryzanol, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate and
campesteryl ferulate, generally had higher antioxidant activity than γ-oryzanol and among them,
24-methylene cycloartanyl ferulate was found to be relatively more effective and could be more
powerful than α-tocopherol. A synergistic antioxidant activity among γ-oryzanol, ferulic acid
and α-tocopherol was also found. With regard to the hypocholesterolemic capacity of γ-oryzanol,
the results suggested that the intact γ-oryzanol was poorly absorbed by intestinal cells in vitro.
Therefore, it was speculated that the effect of γ-oryzanol might take place in the lumen of
gastrointestinal tract, possibly by means of reducing the micellar solubility of cholesterol and
cholesteryl esters and inhibiting cholesterol esterase-facilitated cholesteryl ester hydrolysis. The
results showed that preincubation of cholesterol and γ-oryzanol for six hours significantly
reduced the cholesterol uptake into cells. γ-Oryzanol also showed a trend towards inhibition of
cholesteryl esterase, which is responsible for hydrolyzing cholesteryl esters to free cholesterol
x

before uptake. The results of in vitro digestibility studies of γ-oryzanol showed that the ester
bond of γ-oryzanol, especially campesteryl ferulate and sitosteryl ferulate, was broken down by
cholesterol esterase and produced triterpene alcohols or sterols and ferulic acid, which were
further degraded. The degradation of γ-oryzanol in the stomach may undergo a different pathway
because sterols or triterpene alcohols were also not found after peptic digestion.

xi

CHAPTER 1. INTRODUCTION
While the international scientific research community has recognized the health
promoting potential of rice bran for many years, the rice-processing industry in the United States
has just recently begun to explore and develop its commercially feasible utilization. In this study,
the background of γ-oryzanol and rice bran including sources, analytical methods, toxicity,
metabolism and potential functionality was reviewed (Chapter 2).
γ-Oryzanol

has

been

suggested

to

have

potential

functionality

such

as

hypocholesterolemic capability and antioxidant activity. The goal of this study was to develop
cell culture models as tools to study these two potential aspects of functionality (Chapter 3 and
Chapter 4) and digestibility (Chapter 5) of γ-oryzanol. Using cell culture models enables us to
speculate and monitor a particular biochemical reaction to a certain cell type in humans in a less
expensive and invasive way.
γ-Oryzanol components have been found to have higher antioxidant activity than vitamin
E components in some chemical models. One of the objectives was to determine the antioxidant
activity of γ-oryzanol and its three major components, cycloartenyl ferulate, 24-methylene
cycloartanyl ferulate and campesteryl ferulate, and compare them to ferulic acid and αtocopherol using tert-butyl hydroperoxide (tBHP) induced oxidation on an in vitro mouse
lymphatic endothelial cell (SVEC4-10) model. The critical conditions to develop a cell culture
model and the effects of γ-oryzanol incorporation with cells before tBHP oxidation on its
antioxidant activity and synergistic antioxidant activity with ferulic acid and α-tocopherol were
also discussed.
Some studies have shown that the serum and liver cholesterol levels in rats were lowered
after the consumption of rice bran oil or dietary γ-oryzanol feeding. Another objective of this
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study was then to explore the hypocholesterolemic effects of γ-oryzanol focusing on cholesterol
uptake into human intestinal cells (C2BBe1) in vitro. It has been believed that a reduced
cholesterol uptake or an increase of fecal cholesterol excretion would correspond to decreased
serum total cholesterol levels and the cholesteryl esters in the gastrointestinal lumen should be
hydrolyzed by cholesterol esterase before absorption. Hence, the functions of γ-oryzanol on
cholesterol uptake into C2BBe1 cells in vitro investigated in this study were the effects of γoryzanol on reducing micellar solubility of cholesterol and cholesteryl esters and on inhibiting
cholesterol esterase-facilitated cholesteryl ester hydrolysis.
Additionally, there has been little information published in regard to the digestibility, the
metabolic fate and toxicity of digest products and metabolites of γ-oryzanol in humans. To
further understand where the functionality of γ-oryzanol takes place and how it functions relies
on the fate of γ-oryzanol after ingestion. Therefore, digestibility of γ-oryzanol with emphasis on
peptic and pancreatic digestions and the effect of three pancreatic enzymes, cholesterol esterase,
lipase and phospholipase A2, and the uptake of intact γ-oryzanol into C2BBe1 cells were also
studied.
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CHAPTER 2. LITERATURE REVIEW
2.1 Rice Bran and Oryzanol
Rice bran is a relatively abundant byproduct of rice milling. Rice bran oil for food use
produced commercially in the United States started in 1994, while it has been extensively
consumed in many Asian countries. The annual world rice bran oil production is estimated to be
less than 800,000 metric tons or about only 1% of all vegetable oils (McCaskill and Zhang,
1999). With the rising awareness of functional food consumption, the demand, value and
production are expected to be higher.
A rice kernel consists of 20% hull, 72% endosperm, 6% bran, and 2% germ (Figure 2.1)
(Juliano and Bechtel, 1985; Lu and Luh, 1991). Rice bran is the soft germ and several soft layers,
pericarp, seed coat, nucellus and aleurone layer, surrounding the hard starchy endosperm. Rice
bran contains 15-20% oil, generally the same as soybeans, 12-16% proteins, 34-52% available
carbohydrates, 7-11% crude fiber, and 7-10% ash. The typical crude rice bran oil is composed of
68-71% triacylglycerols, 2-3% diacylglycerols, 5-6% monoacylglycerols, 2-3% free fatty acids,
5-7% glycolipids, 3-4% phospholipids (mainly phosphatidylcholine, phosphatidylethanolamine
and phosphatidylinositol), 2-3% waxes, and 4.2% unsaponifiable fraction (McCaskill and Zhang,
1999; Sayre and Saunders, 1990). Free fatty acids, monoacylglycerols and diacylglycerols are
associated with enzymatic hydrolysis. Sterols, existing as free or esterified, are the major portion
in the unsaponifiable fraction and classified as 1) 4-desmethylsterols, i.e. normal phytosterols
without methyl groups at C-4 position; 2) 4-monomethylsterols and 3) 4,4’-dimethylsterols, also
known as triterpene alcohols. Rice bran oil contains more non-triacylglycerol components than
most vegetable oils but these are lost during refining processes.
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Figure 2.1. Rice kernel structure adapted from Orthoefer, 1996
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Oryzanol occurs in the unsaponifiable fraction of rice bran oil and is so named because it
was first discovered in rice bran oil (Orysae Sativa L.) (Kaneko and Tsuchiya, 1954) and
contained a hydroxyl group. Oryzanol was originally considered a single compound but later was
determined to be a mixture of ferulic acids esterified with normal sterols or triterpene alcohols,
called α-, β- and γ-oryzanol, of which γ-oryzanol has been the most commonly mentioned. The
sterol components of γ-oryzanol are primarily campesterol and sitosterol, and the triterpene
alcohol components are cycloartenol and 24-methylene cycloartanol (Figure 2.2(b)). The content
of γ-oryzanol in rice bran oil can range from 1-3% (Seetharamaiah and Prabhakar, 1986),
depending on the rice varieties and analytical methods. The most accessible natural source of γoryzanol is rice bran, but some components of γ-oryzanol, mainly sitostanyl ferulate and
campestanyl ferulate and lesser amounts of sitosteryl ferulate and campesteryl ferulate, can also
be found mostly in the inner pericarp of corn, wheat, rye and triticale grains (Seitz, 1989).
2.2 Biological Aspect of γ-Oryzanol
The biological function of γ-oryzanol in the plant has not been clearly described. Since it
is a mixture of ferulate esters with sterols or triterpenes, one may view it from two standpoints,
triterpenes or sterols and ferulic acid. Triterpenoids can be categorized under the class
synonymously named terpenoids, terpenes or isoprenoids, which are various, widespread and
numerous natural products derived from a common biosynthetic pathway based on mevalonate
as the parent compound, with the important subclass of steroids (Banthorpe, 1991). The general
pathway of biosynthesis (Figure 2.3) is enzymatically controlled and starts from acetyl-CoA, to
mevalonate, to 2E,6E-farnesyl pyrophophate, to squalene, and then to triterpenoids, with a final
chair-boat-chair-boat configuration (Bramley, 1997). Phytosterols are further formed from
triterpenoids or cycloartenol, which plants apparently use (Connolly and Hill, 1991), involving
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the removal of three methyl groups in the sequence C-4, C-14 and then C-4 ((see Figure 2.2(a)
for numbering system according to IUPAC-IUB (1989); Bramley (1997); and Goad (1991)). The
initial pathway from acetyl-CoA to squalene is common to all organisms, but the sequence of the
modifications of the sterol ring system and side chain can differ from species or even in various
tissues or during different developmental stages in a plant. Sterol production supposedly occurs
in the cytosolic and microsomal compartments of the plant cells.
Phytosterols play a structural role in plant cells as an essential membrane constituent by
analogy with cholesterol in animal cells (Goad, 1991), which regulates its fluidity and enhances
the mechanical stability of the membrane. The plasma membrane has the highest level of sterols
and the greatest ratio of sterol:phospholipid. The endoplasmic reticulum has a lower content and
the mitochondrial and the chloroplast membranes contain a small amount of free sterol. Sterols
are important for plant growth in two ways. One is for new membrane production by dividing
cells and the other is for a 24-ethylsterol such as stigmasterol for specific stimulatory function
for cell division to proceed.
On the other hand, ferulic acid is initially converted from phenylalanine and tyrosine by
enzymes (Figure 2.4) (Graf, 1992) and much of the ferulic acid occurs as esters in many plants,
which may imply the pathway further undergoes conjugation with other molecules. The
biological role of ferulic acid has been suggested to crosslink some cell components and lower
their availability to hydrolytic degradation by endosperm enzymes and thus inhibit germination.
In addition, some studies imply a defensive role of ferulic acid with repellent property and a
physiological function in plant mineral metabolism.

9

COOH
NH 2

COOH

phenylalanine

OCH3
OH

COOH
NH 2

ferulic acid

OH

tyrosine
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2.3 Development of γ-Oryzanol Analysis
It has been established that γ-oryzanol is a mixture and the number of individual
components found in γ-oryzanol depends on the chromatographic approaches. Normal-phase
high performance liquid chromatography (HPLC) used by Diack and Saska, 1994, could only
separate γ-oryzanol into two fractions and each fraction contained at least two or more
constituents. Identification and quantification of each individual component of γ-oryzanol would
be difficult due to incomplete separation. Reverse-phase HPLC, on the other hand, could identify
five (Norton, 1995) or six (Evershed et al., 1988; Rogers et al., 1993) individual components of
γ-oryzanol. Furthermore, Xu and Godber, 1999, successfully separated and identified ten
components of γ-oryzanol from rice bran oil using preparative normal-phase HPLC to
concentrate γ-oryzanol and to reduce interfering substances and reverse-phase HPLC to isolate
and collect each component (Figure 2.5). These ten components were identified as ∆7stigmastenyl ferulate, stigmasteryl ferulate, cycloartenyl ferulate, 24-methylenecycloartanyl
ferulate, ∆7-campestenyl ferulate, campesteryl ferulate, ∆7-sitostenyl ferulate, sitosteryl ferulate,
campestanyl ferulate and sitostanyl ferulate (see Figure 2.2(b) for chemical structures). The three
major components among these are cycloartenyl ferulate, 24-methylenecycloartanyl ferulate and
campesteryl ferulate.
2.4 Influence of Rice Bran and Rice Bran Oil Processing on γ-Oryzanol
After milling, hydrolytic rancidity by enzymes in the bran occurs rapidly. Methods
developed to accomplish stabilization are heating with an extruder or microwave oven, freezing
and treating with chemicals. Therefore, after being abraded during rice milling, bran is
commonly stabilized by extrusion to inactivate the indigenous lipase and prevent further
hydrolysis and the production of free fatty acids and glycerol.
11
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The stability and storability of γ-oryzanol in rice bran after extrusion has been studied by
Shin et al., 1997. Rice bran was extruded at temperatures ranging from 110 to 140oC with post
extrusion holding times 0, 3, and 6 minutes. γ-Oryzanol, total vitamin E and free fatty acids
contents were detected after each treatment at 0 and 7 to 375 days of storage time. It was found
that the post extrusion holding time had no effect on hydrolytic stability and the extrusion
temperature at 110oC was less effective. The loss of γ-oryzanol and total vitamin E increased
when the extrusion temperature increased, which were in a temperature-dependent manner, but
the degree of total vitamin E loss was greater than that of γ-oryzanol loss. The total vitamin E
content decreased when the holding time increased, while γ-oryzanol content decreased only
after 6 minutes of holding time. Additionally, during storage after extrusion, most of the total
vitamin E was lost by 210 days of storage, while the degradation rate of γ-oryzanol was constant
and more than one third of γ-oryzanol was still present throughout storage. In summary, γoryzanol was more stable than vitamin E to the heat of extrusion and decomposition after
extrusion during one year of storage at ambient temperature.
After rice bran stabilization, crude rice bran oil is extracted and then refined before
human consumption. The process of rice bran oil refining usually involves degumming,
neutralization, bleaching, deodorization, and hydrogenation. It has been reported that, in general,
the total sterol loss after oil refining may be between 10 to 70%, depending on the type of oil and
the processing conditions employed, and the sterol content gradually decreases in each step of
the refining process (Kochhar, 1983).
In the neutralization step, the use of alkali such as caustic soda (NaOH) to remove free
fatty acids forms soapstock with a significant amount of γ-oryzanol, which is later separated by
settling or centrifugation. The soapstock can be reacidified to yield dark acid oil, in which the
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free fatty acids can be distilled under high vacuum and leaves γ-oryzanol in the residue called
pitch. It has been proposed to recover γ-oryzanol from the inexpensive pitch as a valuable
byproduct (Das et al., 1998). In the bleaching step, the purpose is to remove color materials by
heating to 85oC and treating with adsorbants such as activated carbon and activated bleaching
earth. It has been recorded that partial modification of sterols, i.e. dehydration and oxidation, and
deacylation of sterol esters may occur during bleaching. In the deodorization step to remove
volatile compounds with undesirable flavors, steam distillation under reduced pressure is usually
used with the expectation that nonvolatile off-flavor substances will be thermally degraded,
become volatile and be distilled away.
Finally, the hydrogenation process, which is important in the oil industry, allows the
liquid oils to be converted into semisolid or solid fats for special applications such as margarine.
The process is to add hydrogen to double bonds in the fatty acid chains, which are susceptible to
oxidation, and thus also improves the oxidative stability of the oil. The effect of bleaching,
deodorization and hydrogenation on γ-oryzanol content in refined oil has not been clearly
studied, which may be related to the fact that γ-oryzanol is mainly lost after neutralization.
However, since it has been noted that γ-oryzanol has several double bonds and possesses
antioxidant activity, if it survives neutralization, γ-oryzanol content may further decrease during
these steps where oxidation may occur.
Not only γ-oryzanol but also tocotrienols are lost during each step of rice bran oil refining
process, and after processing, up to 90% can be lost. This implies that new refining methods for
rice bran oil must be developed and the recoveries of these beneficial ingredients must be well
optimized in order to increase the value of rice bran oil.
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2.5 Toxicology and Carcinogenicity Studies of γ-Oryzanol
The safety of γ-oryzanol for human consumption was tested by toxicology studies on rats
fed a diet containing 10% rice bran oil compared to groundnut oil for three generations
(Rukmini, 1988). The chemical composition between these two oils was similar, except the
unsaponifiable matter of rice bran oil (4.1%) was higher. The rice bran oil effect on the growth
performance, including weight gain and feed efficiency, was not significantly different and the
effect on fat absorption and the retention of nitrogen, phosphorus and calcium was not
significantly different. Moreover, the toxicological effect of rice bran oil on reproductive
performance was evaluated for two matings and three generations. The results indicated that no
abnormalities were found, which were comparable to groundnut oil groups on the percentage of
conception, birth weight, litter size, weaning weight, preweaning mortality and the number of
days taken to deliver from the date of introduction for mating. The mutagenic potential of rice
bran oil for deep frying and repeated heating was also found to be negative, which demonstrated
remarkable oxidative stability.
Furthermore, the short-term safety of γ-oryzanol was assessed using the Rec assay
(bacterial DNA repair test), the Ames test (bacterial reverse mutation test), the rat bone marrow
chromosome aberration test, and the metabolic cooperation inhibition test using Chinese hamster
V79 cells (Tsushimoto et al., 1991). γ-Oryzanol showed negative responses to all these tests.
Additionally, potential carcinogenesis of γ-oryzanol was studied by feeding mice a diet
containing γ-oryzanol up to 2g/kg body weight/day for 78 weeks (Tamagawa et al., 1992b) and
feeding rats for 2 years (Tamagawa et al., 1992a). No treatment-related change was found in
general condition, food consumption, mortality, organ weight and hematology. Histopathological
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examination showed that the tumor incidents were not significantly different between the treated
groups and the control groups.
Modifying effects of γ-oryzanol were also studied in a rat wide-spectrum organ
carcinogenesis model (Hirose et al., 1991). The three combined carcinogens used were 2,2’dihydroxy-di-n-propylnitrosamine (1g/kg body weight ×2 i.p. injections), N-etyhl-Nhydroxyethylnitrosamine (1.5g/kg body weight ×2 i.g. administration) and 3,2’-dimethyl-4aminobiphenyl (75mg/kg body weight ×3 subcutaneous injections) treatment at intervals of 3 to
4 days. One week after the combined treatment, the animals were fed a basal diet containing 1%
γ-oryzanol for 32 weeks and then sacrificed for complete autopsy. The results showed that the γoryzanol treatment tended to lower the incidences of pancreatic eosinophilic foci and liver
hyperplastic nodule and hepatocellular carcinoma, but increased the incidences of lung adenoma
and carcinoma. However, the 1% γ-oryzanol dose given in their study was 100 to 150 times
higher than what γ-oryzanol is usually given for medical use (>300mg/person/day). Also, the
correlation between γ-oryzanol ingestion and human lung cancer and the interaction with other
ingredients in the diet have not been reported in any epidemiological data.
On the other hand, another study of modifying effects on carcinogenesis was
demonstrated using a similar animal model (Imaida et al., 1990) but with two different combined
carcinogens, 1,2-dimethylhydrazine (40mg/kg body weight ×3 subcutaneous injections within
one week) and 1-methyl-1-nitrosourea (20mg/kg body weight ×2 i.p. administrations, twice a
week for 2 weeks). The animals were then on a diet containing 1% ferulic acid until autopsy at
the 52nd week. The combined carcinogens could cause initiation in many organs such as
forestomach, glandular stomach, alimentary tract, urinary bladder, kidney, lung, nervous system,
mammary gland and hematopoietic system and induce colon carcinomas in rats. The results
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showed that 1% ferulic acid had weak inhibitory effect and did not promote lung adenoma and
carcinoma as γ-oryzanol did in the study by Hirose et al. (1991).
Finally, γ-oryzanol and its four major components, cycloartenyl ferulate, 24-methylene
cycloartanyl ferulate, campesteryl ferulate and sitosteryl ferulate have been reported to have an
inhibitory effect on tumor promotion in two-staged carcinogenesis in mouse skin (Yasukawa et
al., 1998). Both the inner and outer surfaces of the ear of each mouse were treated topically with
γ-oryzanol

and

its

components

at

different

concentrations,

followed

by

12-O-

tetradecanoylphorbol-13-acetate (TPA) (1µg/ear) to induce inflammation. The ear thickness was
determined to compare the anti-inflammatory activities. The results showed that, while γoryzanol had no significant effect, its four components had inhibitory activities in a
concentration-dependent manner. Their 50% inhibitory dose was lower than quercetin, a known
tumor inhibitor, similar to indomethacin and higher than hydrocortisone. The inhibitory ratio was
higher than quercetin and comparable with indomethacin and hydrocortisone. Furthermore, the
TPA promoting effect on papillomas induced by 7,12-di-methylbenz[a]anthracene was
remarkably inhibited by cycloartenyl ferulate. Esterification of triterpenes with ferulic acid had
no influence, but sitosteryl ferulate was found more effective than free sitosterol. Interestingly,
the topical application of γ-oryzanol was found to significantly increase sebaceous secretion of
the skin, turnover of sebaceous gland cells and peripheral blood flow, which indicated that γoryzanol may be useful to repair damaged or dry skin. In fact, γ-oryzanol has been used in skin
lotion for its cosmetic and pharmaceutical effects.
In summary, γ-oryzanol has been approved and commercially available in many countries
such as Japan but government and industry in the United States are comparably more
conservative. Studies suggest that γ-oryzanol is not carcinogenic to animals and rice bran oil was
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safe for human consumption. There have been no reported acute or chronic side effects of γoryzanol and the evidence of its beneficial effects in humans is increasing and the market is
growing. Thus, extensive and well-designed clinical trials with regard to the potential of γoryzanol and ferulic acid as chemopreventors or promoters and the mechanisms for carcinogenic
or anticarcinogenic effects are needed.
2.6 Digestibility, Absorption and Metabolism of γ-Oryzanol
While γ-oryzanol has been utilized in many countries as food additives and
pharmaceuticals, there are only a few studies in English exploring the digestibility of γ-oryzanol
in the human gastrointestinal tract. Many of the studies used animal models such as rabbits and
rats and they were also done using thin layer chromatography in the period when the analytical
method to identify γ-oryzanol and its metabolites was not advanced.
One of the few studies about absorption, metabolism and lymphatic transport of γoryzanol -14C orally administered to rats (50 mg/kg) was by Fujiwara et al., 1983. After 72 hours
of administration, 9.8% radioactivity was found in urine and 84.5% was in feces. That found in
the urine was not intact γ-oryzanol but identified as the major metabolites such as ferulic acid,
dihydroferulic acid, m-hydroxyphenylpropionic acid, m-coumaric acid, m-hydroxyhippuric acid,
hippuric acid (see Figure 2.6 for chemical structures) and also their conjugated forms with
glucuronide or sulfate. In their experiment of in situ absorption at the mid-ileal portion of the
intestines, the results showed that 89.4% of the dose remained in the luminal fluid with more
than 95% intact and only 0.2% found in mesenteric vein as intact esters, which suggests that γoryzanol was poorly absorbed. Additionally, it was also found that only 0.3% of the dose was
transported into the thoracic duct, of which more than 80% was intact γ-oryzanol by thin layer
chromatography. Therefore, it was assumed that the absorbed γ-oryzanol from oral
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administration mainly went through the portal vein system instead of the lymph via the thoracic
duct. In their study, the radioactivity found in feces was not tested as to whether it was the intact
γ-oryzanol or its metabolites. It was reported that the ester linkage of γ-oryzanol was partly
hydrolyzed in the intestine during absorption; however, the digestibility of γ-oryzanol going
through the stomach, duodenum and jejunum was not discussed.
Even though the digestibility of γ-oryzanol has not been fully studied, absorption of plant
sterols by the human body has been investigated. It was found that the plasma levels of plant
sterols were very low, approximately only 5% of ingested plant sterols are absorbed, and
suggested that the absorption was limited, except for those with a rare genetic disorder,
sitosterolemia, which increases the absorption rate of plant sterols (Moghadasian, 2000). The
accumulation of sitosterol in plasma and tissues of a sitosterolemic patient accounted for the
increased sitosterol absorption rate and the decreased elimination rate and symptoms include
tendon xanthomas, accelerated atherosclerosis, hemolytic episodes, arthritis and arthralgias and
was observed mostly in young males.
Therefore, to fully understand the fate of γ-oryzanol in the human digestive system,
further research is required. In this study, the in vitro digestibility of γ-oryzanol by pepsin and
pancreatic enzymes such as cholesterol esterase, phospholipase A2 and lipase was inspired and
the absorbability of γ-oryzanol was demonstrated in a human intestinal cell model.
2.7 In Vitro Cell Culture Models
Tissue culture, commonly used as a generic term to refer to organ culture and cell culture
as well as tissue culture, was first devised at the beginning of the 20th century. The term cell
culture implies a culture derived from dispersed cells taken from original tissue or from a cell
line. Tissue culture techniques can be applied for studies in toxicology, virology, immunology,
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cancer research and so on. The advantages of tissue culture are control of physiochemical
environment (pH, temperature, O2) and physiological conditions (hormone, nutrients),
production of homogeneous culture to reduce variance, avoidance of the ethical questions of
animal experimentation, and economic with availability of microtitration and robotics and with
direct access to the cell and consequently less use of reagent.
2.7.1 Cell Selection
To select a cell line, besides the specific function to be studied, there are a number of
parameters to be considered (Freshney, 2000): 1) Finite or continuous cell line; a continuous cell
line usually grows faster and is easy to maintain. 2) Normal or transformed cell line. 3) Species;
non-human cell lines are more accessible and have fewer biohazard restrictions. 4) Growth
characteristics such as population-doubling time, yield and cloning efficiency. 5) Availability. 6)
Validation; how well the cell line is characterized as acceptable. 7) Phenotypic expression; if the
cell line is made to express the right characteristics. 8) Control cell line; if a normal equivalent
cell line is required when using a transformed or abnormal cell line. 9) Stability; how the cell line
is stable and can be generated into sufficient frozen and usable stocks.
However, there are also limitations in developing and using in vitro cell models. One is
the requirement of expertise due to the strict aseptic culture conditions to avoid chemical or
microbial contamination and the handling of biohazard disposal. Secondly, cells may lose the
phenotypic characteristics and not function as they should. Many continuous cell lines may also
show variability from passage to passage. Other limitations include the loss of cell-cell
interactions and homeostatic regulations from nervous and endocrine systems and the alteration
of energy metabolism, which may result in cell behavior change and not be truly representative
of the tissue from which the cells were isolated. Even though limitations exist, there are many
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specialized functions expressed and cell culture can still be a valuable tool if the limits are
appreciated.
Cell culture techniques have been used to investigate antioxidant activities and
cholesterol absorption. The cell lines that have been utilized for antioxidant activity studies
include rat hepatocytes (Halpner et al., 1998), bovine aortic and pulmonary artery endothelial
cells (Kapiotis et al., 1997 and Podhaisky et al., 1997), human aortic endothelial cells (Pearson et
al., 1998) and human umbilical vein endothelial cells (Kaneko et al., 1993). The cell lines that
have been used for cholesterol uptake studies include human intestinal cells, Caco-2, (Mackay et
al., 1997 and Lopez-Candales et al., 1993) and rat intestinal cells (Young and Hui, 1999). In this
study, because of its availability, growing efficiency and established utility, a mouse endothelial
cell line (SVEC4-10) derived from axillary lymph node vessels was used to examine antioxidant
activity of γ-oryzanol and a human intestinal cell line (C2BBe1) was used to investigate the γoryzanol effect on cholesterol uptake.
2.7.2 Cell Viability Assays
Cell viability assays are immediate or short-term responses from cells such as a variation
in membrane permeability or a disturbance of a particular metabolic pathway, usually obtained
when they encounter a new environment of interest. There are several assays available, which
have been described in many publications (i.e. antioxidant activity studies), including dye
exclusion, crystal violet assay, lactate dehydrogenase (LDH) assay and [3-(4,5-Dimethylthiazolyl)-2-5-Diphenyltetrazolium Bromide (MTT) assay.
Dye exclusion is a basic technique often employed in routine practice. Trypan blue is
usually used and is impermeable to viable cells. However, this method does not always predict
ultimate survival and tends to overestimate viability. The crystal violet assay is a fixed cell
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staining. It is inexpensive and easy to use but it nonspecifically stains protein, which may not
necessarily measure cell viability. The LDH assay is a method used to evaluate cell viability in
terms of the degree of cell membrane integrity. An LDH assay kit can be purchased
commercially. It is used to detect LDH released from surviving or dead cells. The MTT assay is
a widely chosen method to estimate the number of viable cells, whose mitochondrial
dehydrogenases can reduce the yellow tetrazolium dye to a purple formazan product. The
selection of viability assay depends on availability and avoidance of reacting with the test
substances.
2.8 Emulsion Preparation for γ-Oryzanol and Lipophilic Substances
Since γ-oryzanol is not water soluble, it has been a challenge to prepare physiological
aqueous solutions containing γ-oryzanol and other hydrophobic or lipophilic substances for cell
culture studies. Emulsifiers or surfactants are usually involved, which function to create surfacetension gradients and to deform the interface. They are amphipathic compounds, which contain
both polar and nonpolar regions. Many biomolecules are amphipathic such as proteins,
phospholipids and bile salts. When dispersed in water, the lipid portions force surrounding water
molecules to become highly ordered and clusters of lipid molecules are formed. Then all
hydrophobic groups are sequestered from water and form a stable structure called micelles with
the hydrophobic regions inside by the force of hydrophobic interaction and the hydrophilic
regions at the surface.
Micelle formation plays very important roles in digestion, mobilization and transport of
lipids. Before being absorbed through the intestinal wall, dietary lipids must be converted to
finely dispersed microscopic micelles with the help of amphipathic compounds, i.e. bile salts,
such as taurocholate acting as biological detergents. Bile salts are synthesized from cholesterol in
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the liver, stored in the gallbladder and released into the duodenum. The formation of micelles
increases the action of water-soluble lipase to convert triacylglycerols into monoacylglycerols,
diacylglycerols, free fatty acids and glycerol, which can diffuse into the epithelial cells lining the
intestinal surface (the intestinal mucosa). Those lipase products are then reconverted to
triacylglycerols and incorporated with dietary cholesterol and apolipoproteins into chylomicrons.
Apolipoproteins, also amphipathic, are lipid-binding proteins in the blood responsible for the
transport of triacylglycerols, phospholipids, cholesterol and cholesteryl esters between organs.
Chylomicrons travel through the lymphatic system and bloodstream to tissues and form several
classes of lipoproteins named very low-density lipoproteins (VLDL), low-density lipoproteins
(LDL) and high-density lipoproteins (HDL), according to the combinations of lipids that change
constantly and cause different densities.
Therefore, phosphatidylcholine and bovine serum albumin were used to prepare γoryzanol emulsion to demonstrate the antioxidant effect of γ-oryzanol on protecting against
oxidative

stress

to

mouse

lymphatic

endothelial

cells.

Oleic

acid,

1-monoolein,

phosphatidylcholine and sodium taurocholate were used to prepare micelles containing γoryzanol to study γ-oryzanol digestibility and hypocholesterolemic capacity of γ-oryzanol taking
place in human intestinal cells.
2.9 The Potential Functionality of γ-Oryzanol to Human Health
The concepts of food and nutrition are changing from a focus on preventing hunger and
adverse effects on health and improving nutrition for health maintenance to a recognition that
food may reduce morbidity and mortality from chronic diseases such as cardiovascular disease,
cancers and obesity. Therefore, the science of functional foods, defined as nutrients or nonnutrients that play a role in affecting one or more targeted functions in the body in a positive way
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(i.e. preventing disease) beyond the prevention or correction of nutrient deficiency, is becoming
an emerging field. The term chemoprevention is sometimes used with emphasis on the function
to decrease the incidence of disease by using specific chemicals, either alone or in combinations.
Requirements would be that they lack significant toxicity and are easy to be supplemented for
large sections of the populations.
γ-Oryzanol has been suggested to have potential functionality such as antioxidant activity
(Xu and Godber, 2001), reduction of serum cholesterol (Sasaki et al., 1990), reduction of
cholesterol absorption and decrease of early atherosclerosis (Rong et al., 1997), inhibition on
platelet aggregation (Seetharamaiah et al., 1990) and inhibition of tumor promotion (Yasukawa
et al., 1998). Hence, this study was inspired to focus on the functionality of γ-oryzanol including
antioxidant activity and hypocholesterolemic capacity and the possible mechanisms of actions as
determined using in vitro cell culture models.
2.9.1 Antioxidant Activity
In order to understand the function of antioxidants, first of all, the oxidative stress caused
by the generation of reactive oxygen species (ROS) associated with the presence of oxygen even
under physiological conditions and the antioxidant defense system in human organisms must be
discussed. ROS are either radicals, atoms or a group of atoms that contain at least one unpaired
electron, such as peroxyl radicals (ROO•), hydroxyl radicals (•OH−), the nitric oxide radical
(NO•) and the superoxide anion radical (O2•−), or non-radical compounds, such as hydrogen
peroxide (H2O2) and singlet oxygen (1O2), which are capable of oxidizing molecules. ROS may
have positive, negative or zero charge and sometimes are also called oxidants or prooxidants.
The origins of ROS can be from normal human metabolism (endogenous source) starting
with O2•−, generated by enzymatic one-electron reduction of O from xanthine oxidase, NADPH
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oxidase, and other reactive intermediates such as H2O2 and •OH−. The other endogenous source
of ROS is generated as part of the primary immune defense by phagocytic cells such as
neutrophils, monocytes or macrophages, which synthesize large amounts of O2•− and NO•
against foreign organisms. Human organisms are also exposed to ROS (external sources) such as
diet, cigarette smoke and ozone due to air pollution.
The antioxidant defense system in vivo includes enzymatic and non-enzymatic
antioxidants, which are defined as any substances that in a relatively low concentration compared
with substrate significantly delay or inhibit the oxidation of that substrate. The major enzymatic
antioxidants are superoxide dismutase (O2•−→ H2O2), catalase (H2O2→ H2O), glutathione
peroxidase (organic hydroperoxides ROOH→ H2O) with glutathione (GSH→GSSH),
glutathione reductase to restore GSH from GSSH, glutathione-S-transferases (conjugation with
some reactive intermediate products) and metal-binding proteins (ferritin and transferrin,
prevention of initiation of lipid peroxidation or DNA damage).
The non-enzymatic antioxidants are dietary antioxidants among which the most
prominent are ascorbic acid (vitamin C), tocopherols and tocotrienols (vitamin E), carotenoids
and flavonoids. Vitamin C acts as a scavenger of ROS, is most effective against O2•−, H2O2,
•

OH− and 1O2, and forms ascorbyl radical. Vitamin E is a scavenger of ROO•, is more important

in inhibiting lipid peroxidation, and yields tocopheroxyl radical, which is less reactive and acts as
a chain-breaking antioxidant. Carotenoids are natural colorants and scavengers of 1O2 and ROO•
(physical quenching by energy transfer and chemical quenching by interaction with radicals).
Flavonoids are polyphenolic antioxidants that can scavenge ROO•, O2•− and •OH− and form
phenoxy radicals.
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It has been suggested that ROS are involved in numerous diseases such as cardiovascular
diseases, cancer, cataract and age-related macular degeneration, neuronal diseases and so on. For
example, the main cause of many cardiovascular diseases is thought to be atherosclerosis in the
artery wall, which is fatty streaks containing large cytoplasmic lipid deposits of free and
esterified cholesterol formed in the subendothelial space. This occurs by way of aggregation of
foam cells, which are of macrophage origin, with smooth muscle cells comprising the rest. There
is increasing evidence that LDL oxidation initiated by radicals is responsible for the pathogenic
pathway and lipophilic antioxidants such as α-tocopherol are very effective to inhibit LDL
oxidation. Therefore, antioxidants play important roles in preventing oxidative damage to bodily
functions and dietary antioxidant intake is expected to lower the risk of a number of ROS-related
diseases.
Direct measurement of prooxidants in vivo is difficult; however, there are many studies
that have established using in vitro models in order to speculate relative to in vivo antioxidant
action. Generally, the models constructed to study antioxidant activity of a compound or mixture
consist of three parts: 1) ROS generators to initiate oxidation reactions, i.e. 2,2’-azobis(2methylpropionamidine)

dihydrochloride

(AAPH),

2,2’-azinobis(3-ethylbenzothiazoline-6-

sulfonic acid (ABTS•+), 2,2’-azobis-2,4-dimethyl valeronitrile (AMVN), air (oxygen), UV and
oxidizing agents such tert-butyl hydroperoxide (tBHP) and H2O2. 2) Substrates that are the
targets of ROS, i.e. cholesterol, fatty acids such as linoleic acid, fluorescent probe such as
fluorescein, LDL and cells cultured in vitro. The degree of oxidative damage to the substrates
prevented by the test compound is usually determined directly or indirectly through the decrease
of substrates (i.e. fluorescence decay and cell viability) or the increase of oxidized products (i.e.
oxidized cholesterol, oxidized linoleic acid, lipid peroxidation intermediates such as
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thiobarbituric acid reactive substances (TBA-RS) and conjugated dienes). 3) detection methods
to allow monitoring the action such as HPLC for lipid hydroperoxides, spectrometer,
spectrofluorometer and cell viability assays.
The antioxidant activity of γ-oryzanol has been evaluated in a few models using
chemicals to induce oxidation and measuring the generation of oxidized products. One of them is
a cholesterol oxidation model accelerated by AAPH, which was established to compare the
inhibitory capability of γ-oryzanol and vitamin E on production of oxidized cholesterol (Xu and
Godber, 2001). The antioxidant activity was determined in terms of the degree to which the
generation of seven oxidized cholesterol products (7-α- and -β-hydroperoxycholesterol, 5,6-αand -β-epoxycholesterol, 7-α- and -β-hydroxycholesterol and 7-ketocholesterol) was prevented
in the presence of three major components of γ-oryzanol (cycloartenyl ferulate, 24-methylene
cycloartanyl ferulate and campesteryl ferulate) or vitamin E components (α-tocopherol, γtocopherol, α-tocotrienol, γ-tocotrienol). The results suggested that 24-methylene cycloartanyl
ferulate had the highest antioxidant activity and all three major components of γ-oryzanol had
higher antioxidant activity than vitamin E components.
Another assessment of antioxidant activity of γ-oryzanol using AAPH as a peroxyl
radical generator utilized an oxygen radical absorbance capacity assay (Huang et al., 2002). This
assay used cyclic (α-1,4)-linked oligosaccharides of α-D-gluco-pyranose, which have both
hydrophilic and hydrophobic regions, to prepare lipophilic antioxidants such as vitamin E
isomers and γ-oryzanol, and fluorescein as a target of free radical attack. Antioxidant activity
was determined as the degree to which the fluorescence decay of fluorescein caused by AAPH
was inhibited over time. Similarly, their results showed that γ-oryzanol possessed the greatest
antioxidant activity compared to other antioxidants tested including α-tocopherol, γ-tocopherol,
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δ-tocopherol and tocotrienols, while α-tocopherol acetate had zero effect. It seemed that γoryzanol had the greatest antioxidant activity towards peroxyl radicals generated by AAPH and it
was proposed that the antioxidant mechanism of γ-oryzanol might be due to its intramolecular
hydrogen-bonded methoxyphenols, where hydrogen donation would occur more readily.
It has also been postulated that the phenol group is the key functional group for
antioxidant activity and that steric hindrance around the phenol group decreases antioxidant
activity. For example, in their model of the antioxidant activity of tocopherols, Huang et al.
(2002) found that relative order of antioxidant activity was α< γ< δ and the reason was explained
relative to the number of methyl groups ortho to the phenol group where α has two, γ has one
and δ has zero (see Figure 2.7 for vitamin E structure). The theory has also been approached in a
review of the antioxidant chemistry of ferulic acid (Graf, 1992). It was explained that the
antioxidant activity of ferulic acid is due to its phenolic hydroxyl group that has hydrogen
donating property to scavenge a reactive radical and form a phenoxy radical. This radical is then
stabilized resonantly because the unpaired electron can be delocalized across the entire molecule
(Figure 2.8). The second phenolic hydroxyl group can enhance the radical-scavenging property
by providing additional resonance stabilization and form quinone. The methoxyl group of ferulic
acid partially destabilizes the phenoxy radical and impairs its antioxidant activity.
However, in a study using ABTS•+ as a radical generator to study the antioxidant
activities of benzoic acid or cinnamic acid as a parent acid and other acids (i.e. ferulic acid) with
hydroxyl groups and methoxyl groups at different positions, the results conflicted with the
proposed antioxidant mechanism (Miller and Rice-Evans, 1997). Their results showed that
vanillic acid (3-methoxy-4-hydroxy benzoic acid) had a higher antioxidant activity than 4hydroxy benzoic acid (Figure 2.9 for chemical structures). Two hydroxyl groups attached to
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benzoic acid had higher antioxidant activity than one hydroxyl group but did not necessarily
have higher antioxidant activity than vanillic acid. On the other hand, ferulic acid (3-methoxy-4hydroxy cinnamic acid) did not have higher antioxidant activity than 4-hydroxy cinnamic acid
but had higher antioxidant activity than caffeic acid (3,4-dihydroxy cinnamic acid). Therefore, it
is difficult, with the available evidence, to postulate the relationship between antioxidant activity
and structure and to explain whether or not ferulic acid esterified with sterols or triterpenes (γoryzanol) would have a higher antioxidant activity.
Antioxidant activity of the three major components of γ-oryzanol was also approached in
a linoleic acid model (Xu and Godber, 2001). Antioxidant activity was determined as the degree
of inhibition on hydroperoxide formation that resulted from linoleic acid incubated with air flow
at 37oC for 40 to 200 minutes. There were four hydroperoxide isomers, 9-hydroperoxy-10trans,12-cis-octadecadienoic

acid

[9HPODE(t,c)],

[9HPODE(t,t)],

[13HPODE(c,t)]

and

[13HPODE(t,t)] measured by normal-phase HPLC and UV detection. The results showed that γoryzanol incubated with linoleic acid at molar ratios of 1:100 and 1:250 significantly decreased
the formation of hydroperoxides, especially trans,cis and cis,trans forms, which was similar to
the antioxidant activity of ferulic acid. α-Tocopherol was also tested and showed significant
antioxidant activity but it was more effective in preventing the formation of trans,trans
hydroperoxides, which may indicate a different antioxidant mechanism from that of γ-oryzanol
or ferulic acid. It has been reported that the hydroxyl group in the phenolic ring of ferulic acid
may be responsible for the antioxidant activity. In this case, ferulic acid presented a higher
antioxidant activity than γ-oryzanol, especially at a lower concentration. While γ-oryzanol also
has ferulic acid in its structure, it may suggest that the sterol or triterpene alcohol portion of the
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γ-oryzanol structure may affect the antioxidant activity by reducing the mobility because of the
much larger molecular structure.
In spite of the efforts contributed by these researchers in studies of γ-oryzanol antioxidant
activity, the functionality of γ-oryzanol as an antioxidant in the human body has not been
delineated. One of the objectives of this study, therefore, was to develop a cell culture model in
vitro as a closer approach to the human body and use it to compare the antioxidant activity of γoryzanol and its three major components to α-tocopherol. The cell line used to develop the cell
culture model was SVEC4-10, a mouse endothelial cell line derived by SV40 (strain 4A)
transformation of endothelial cells from axillary lymph node vessels. The oxidizing agent was
tert-hydroperoxide. The MTT, [3-(4,5-dimethylthiazol-yl)-2-5-diphenyltetrazolium bromide,
assay was chosen to measure cellular mitochondrial activity as an index of cell viability. Lipid
peroxidation was also analyzed to detect TBA-RS and conjugated diene formation. Thus, the
antioxidant activity of γ-oryzanol was determined as the degree to which γ-oryzanol preserved
cellular mitochondrial activity and prevented lipid peroxidation from tBHP oxidative damage.
2.9.2 Hypocholesterolemic Capacity
A hypocholesterolemic effect of different vegetable oils blended with rice bran oil was
found in healthy young women fed for 7 days (Suzuki and Osima, 1970). This effect was also
reported in rats fed a normal diet containing 7% rice bran oil or a high cholesterol diet containing
1% cholesterol and 7% rice bran oil for 4-7weeks and there was also significantly decreased
levels of serum and liver total cholesterol and LDL and a slightly increased level of HDL in both
the normal diet and the high cholesterol diet (Sunitha et al., 1997).
It was also discovered that the unsaponifiable fractions in rice bran oil had cholesterollowering potential (Kiribuchi et al., 1983, and Ikeda et al., 1985). It was found that rats fed a

34

cholesterol-enriched (0.5%) diet with 0.05-1% of cycloartenol, 24-methylene cycloartanol and/or
β-sitosterol greatly reduced plasma cholesterol and enhanced cholesterol fecal excretion.
Later, γ-oryzanol was found to be responsible for the effect (Seetharamaiah and
Chandrasekhara, 1989). The rice bran oil (10%) diet showed markedly lower serum and liver
total cholesterol levels in rats and rice bran oil spiked with γ-oryzanol (0.5%) reduced it even
more significantly. This was also confirmed by Rong et al. (1997) in hamsters fed a diet
containing 0.1% cholesterol with or without 1% γ-oryzanol for 7 weeks. The γ-oryzanol-fed
animals had 28% reduction in plasma total cholesterol and 34% reduction of combined LDL and
VLDL, as well as 25% decrease in cholesterol absorption. Moreover, γ-oryzanol showed no
effect on endogenous cholesterol synthesis, as measured by the liver and intestinal HMG-CoA
reductase activities, which is an important indication that the decreased cholesterol level in
plasma may have resulted from lower cholesterol absorption and that cholesterol synthesis by
HMG-CoA reductase may not increase to adjust the cholesterol level in response to the
decreased cholesterol uptake.
There are only a few γ-oryzanol studies on humans. Sasaki et al. (1990) studied the
effects of γ-oryzanol on serum lipids of twenty chronic schizophrenic patients with dyslipidemia.
Each patient was given 100mg of γ-oryzanol three times daily for 16 weeks. The results showed
that total cholesterol and LDL levels decreased significantly with no side effects recorded,
suggesting that γ-oryzanol is safe and effective in the treatment of dyslipidemia.
Since hypercholesterolemia is often a risk factor for many heart diseases associated with
platelet aggregation and atherosclerosis, the cholesterol-lowering potential of γ-oryzanol may
also play important roles in preventing these diseases. The γ-oryzanol effect to reduce early
atherosclerosis was also observed in hamsters fed a diet containing 0.05% cholesterol and 10%
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coconut oil with or without 0.5% γ-oryzanol (Rong et al., 1997). The results showed that the
aortic fatty streak formation, as determined by the degree of accumulation of macrophagederived foam cells, was reduced 67%. In addition, the influence of γ-oryzanol on platelet
aggregation induced by ADP and collagen was also reported in rats fed a 1% cholesterol diet
containing γ-oryzanol (Seetharamaiah et al., 1990). The platelet aggregation in platelet rich
plasma induced by both ADP and collagen was significantly inhibited in γ-oryzanol-treated rats.
In summary, γ-oryzanol has shown promising hypocholesterolemic capacity. To postulate
the hypocholesterolemic mechanism of γ-oryzanol, the cholesterol absorption and transport in
humans must be discussed. The cholesterol in the human body comes from two sources. One is
endogenous cholesterol, which is synthesized in the liver. Some may go into VLDL and be
secreted into the blood and some are converted to bile salts, stored in the gallbladder, released
into the duodenum as biological detergents to form micelles with dietary lipids, reabsorbed at the
ileum and return to the liver through the hepatic portal vein. The other source is exogenous
dietary cholesterol, which is incorporated into micelles, absorbed at the jejunum and travels to
the liver through the lymphatic system and bloodstream. During any one day, the cholesterol in
the intestinal lumen is typically two-thirds from endogenous sources and one-third from dietary
sources. Cholesterol absorption in humans can vary widely (15 to 75%) (Grundy, 1983). It has
been demonstrated that decreased serum cholesterol, specifically LDL, can result from the
inhibition of cholesterol absorption (Gylling and Miettinen, 1995). According to this mechanism,
drugs such as questran and cholestyramine, which are powdered resins that increase excretion of
bile salts have been prescribed by doctors for hypercholesterolemic patients.
Due to the rising controversial issue about using laboratory animals, cell culture models
have been used for many cholesterol uptake and cholesterol synthesis research projects. Since γ-
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oryzanol digestibility is unclear, whether or not γ-oryzanol can be absorbed and function in the
human body i.e. inhibition of cholesterol synthesis in liver is beyond the scope of this study. This
study focused on the γ-oryzanol effects on the availability of cholesterol for uptake into in vitro
human intestinal cells, especially the effects on micellar solubility of cholesterol (free and ester
forms) and on inhibition of cholesterol esterase to hydrolyze cholesteryl esters.
2.10

Applications of γ-Oryzanol
Since the functionality of γ-oryzanol has been found to be promising, rice bran or γ-

oryzanol may have great market potential and be applied to a wide range of products. It can be
enriched in food products such as cereal and margarine for its cholesterol-lowering and
antioxidant effects, put into frying oil for its stability and into food coating or packaging material
for antioxidant potential to extend shelf life. It can also be supplemented into non-food products
such as sun protection skin lotion due to UV absorption and skin-care products for repairing dry
and sensitive skin.

37

CHAPTER 3. ANTIOXIDANT ACTIVITY EXPERIMENTS USING
AN IN VITRO MOUSE LYMPH AXILLARY ENDOTHELIAL CELL MODEL
3.1 Introduction
The potential antioxidant activity of γ-oryzanol has been studied in chemical models such
as in a cholesterol model to reduce cholesterol oxidation accelerated by 2,2’-azobis(2methylpropionamidine) dihydrochloride (Xu et al., 2001) and in a linoleic acid model to prevent
linoleic acid oxidation induced by air (Xu and Godber, 2001). The antioxidant activity of ferulic
acid, part of γ-oryzanol structure, has also been investigated as determined by its ability to
scavenge ABTS•+ radical cation more effectively than vitamin C (Miller and Rice-Evans, 1997)
and to inhibit lipid peroxidation (malondialdehyde production) in rat brain homogenates in vitro
(Sharma, 1976). However, the functionality of γ-oryzanol as an antioxidant in the human body
has not been delineated. The objectives of this study, therefore, were to develop an in vitro cell
model assay as an approach that more closely reflects what might occur in the human body and
use it to evaluate the effect of γ-oryzanol. The latter could be distinguished by testing its ability
to preserve cellular mitochondrial activity from damage caused by tert-hydroperoxide (tBHP)
compared with the effect of α-tocopherol. The antioxidant activity of the three major
components of γ-oryzanol and the possible synergism among γ-oryzanol, ferulic acid and αtocopherol were also studied.
3.2 Materials and Methods
3.2.1 Materials and Reagents
Milled rice bran was obtained from Riviana Rice Mill, Abbeville, LA. Distilled and
deionized water was used to prepare culture media and solutions. Ferulic acid, α-tocopherol,
lecithin, fatty acid free bovine serum albumin, MTT assay kit, LDH test kit, Bradford reagent,
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Hank’s balanced salts, thiobarbituric acid, butylated hydroxytoluene and trypan blue solution
were purchased from Sigma Chemical Co., St. Louis, MO. Sodium bicarbonate and HCl were
purchased from Mallinckrodt, Inc., Paris, KY. All the solvents used were HPLC grade. Methanol
hexane, dichloromethane, acetonitrile, acetic acid and trichloroacetic acid were purchased from
Fisher Scientific, Fair Lawn, NJ. Ethanol was USP absolute 200 proof purchased from AAPER
Alcohol and Chemical Co., Shelbyville, KY. Culture plates, flasks and scrapers were purchased
from Corning Inc., Corning, NY, and the sterile disposable syringe filter was 0.2µm PES
purchased from Whatman, Clifton, NJ.
3.2.2 Extraction of γ-Oryzanol from Rice Bran and Chemical Analysis of γ-Oryzanol, Ferulic
Acid and α-Tocopherol
Solvent extraction of rice bran was done to obtain crude rice bran oil. Two hundred
grams of milled rice bran were mixed with hexane and then filtered and the hexane extraction
was repeated for a total of 3 times. The hexane layer was combined into a round-bottom bottle,
followed by vacuum evaporation (45oC, CentriVap Console, Labconco Inc., Kansas City, MO)
to remove hexane and yield crude oil. To separate γ-oryzanol from the oil, a preparative normalphase high performance liquid chromatography (HPLC) procedure developed by Xu and Godber
(1999) was used. The preparative HPLC system consisted of a Waters (Milford, MA) Prepak®
RCM base connected with two cartridges (each 25mm×10cm Prep Nova-Pak HR silica with
particle size 6µm) and a Guard-Pak insert, a U6K manual injector, a 510 pump and a LambdaMax 481 LC Spectrophotometer (wavelength 330 nm). Mobile phase was methanol with a
constant flow rate at 15 mL/min and 2mL of the crude oil were injected each time. The eluate
containing γ-oryzanol was collected (25-30min) and the solvent was evaporated using a vacuum
evaporator.
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To separate γ-oryzanol fractions, the HPLC system used consisted of a pump (Waters 510
HPLC Pump), an autosampler (Waters 715 Sample Processor), a column (C18, MICROSORBMV 100 Å, Varian) and a UV detector (Waters 486 Tunable Absorbance Detector) at wavelength
330 nm. The mobile phase was methanol, acetonitrile, dichloromethane and acetic acid
(50:44:3:3) and the flow rate was 1.4 mL/min. The γ-oryzanol obtained from rice bran oil was
dissolved in the mobile phase. Ultrasonication was used to help dissolve when necessary. One
hundred µL of γ-oryzanol solution (1.5mg/mL) was injected each time. Cycloartenyl ferulate,
24-methylene cycloartanyl ferulate and campesteryl ferulate were collected (at retention time
5.2-5.8, 5.8-6.3 and 6.3-6.8 minutes, respectively), dried using a vacuum evaporator, sealed with
foil and kept frozen until further experiments.
Determination of γ-oryzanol, ferulic acid and α-tocopherol concentrations was obtained
from retention time comparison and quantifications of known standards. The HPLC system to
analyze α-tocopherol was the same as for γ-oryzanol except that the detector was a Waters 470
Scanning Fluorescence Detector with excitation wavelength set at 290nm and emission at
330nm.
3.2.3 Emulsion Preparation
Because γ-oryzanol and α-tocopherol are hydrophobic, emulsifiers such as lecithin and
bovine serum albumin (BSA) were needed to prepare γ-oryzanol and α-tocopherol in aqueous
culture solutions. γ-Oryzanol, α-tocopherol or ferulic acid was dissolved in ethanol (50mM) and
filtered through 0.2µm filter for sterilization and the concentration was checked by HPLC. Each
was then diluted to make 2mM stock solution in filtered Hank’s balanced salt solution (HBSS)emulsion composed of lecithin and essential fatty acid free BSA, whose concentrations were
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tested first to assess impact on cell viability. The emulsion was then evaluated to be free of
precipitation. For cell culture experiments, the final ethanol concentration did not exceed 2%.
3.2.4 Cell Culture
For antioxidant activity experiments, mouse lymph axillary endothelial cell line,
SVEC4-10 (ATCC CRL-2181), was chosen. The cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) with 4mM L-glutamine, 4.5g/L glucose, 1.5g/L sodium bicarbonate,
15mM N-[2-hydroxyethyl] piperazine-N’-[2-ethanesulfonic acid] (HEPES) and 10% fetal bovine
serum in a 37oC 5% CO2 humidified incubator. To maintain the cell line, cells were detached
from surface using 0.25% trypsin solution and split to new 25-cm2 culture flasks (1:5-1:7 split
ratio). Cells reached confluency to form a monolayer in about 3-4 days.
Cells for antioxidation experiments were cultured in 96-well (12x8) cell culture plates.
After subculture as described above, cell suspension was diluted in new medium to at least 105
cells/mL and 100µL of the diluted cell suspension was transferred to each well. If not all 96
wells were used, only the middle wells of the plate would be used to prevent “edging effect” due
to uneven evaporation and the unused wells were filled with water to maintain humidity. An
exact cell counting was performed at this time (as described below). The plates were kept at
37oC in the humid incubator until they reached confluency (about 3-4 days) for further
experiments.
3.2.4.1 Growth Curve
After obtaining a cell line, it is recommended to construct a growth curve in order to help
understand the cell growth characteristics. Cell counting using dye such as trypan blue and the
hemacytometer is one of the commonly used methods. For adhesive cell lines including the one
used in this project, after trypsinization, 200µL of cell suspension to be counted was mixed with
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200µL 0.4% trypan blue solution. Pipetting up and down at least 20 times was done to break the
cell clumps. A drop of the cell suspension was placed to the edge of one side of the
hemacytometer covered with the coverslip and repeated for the other side. The cell suspension
was drawn by the force of capillary action. The hemacytometer was then transferred to the
microscope with a standard 10x objective. The counting chamber of the hemacytometer
consisted of nine squares and each square had the volume of 10-4mL (1-mm long × 1-mm wide ×
0.1mm deep). For cell viability, only the “sort of healthy” to viable cells, which were
impermeable to trypan blue and appeared clear, were counted, as opposed to sick cells, which
could not exclude dye and appeared dark. At least 100 cells per square were counted. Cell count
was calculated as viable cell numbers per mL, which was the average cell number counted in one
square times 104 and times 2 with 1:1 trypan dilution. Cell counting was done everyday for 6
days after subculture. The SVEC4-10 cell growth curve from subculture was expressed as cell
count in logarithmic scale versus days.
3.2.4.2 MTT and LDH Assays for Cell Viability
To measure cell viability under oxidative stress, an MTT assay kit was used to measure
the activity of mitochondrial dehydrogenases in living cells. After the test solution was removed
and the cells were washed three times with HBSS, 40µL of 1.25mg/mL MTT in HBSS, which is
yellow color, was added to cells. After incubation at 37oC in the dark for 2 hours, the
mitochondrial dehydrogenases of viable cells cleaved the tetrazolium ring and yielded purple
formazan crystals, which are insoluble in aqueous solution. Then 100µL/well of MTT
solubilization solution containing 10% Triton X-100 plus 0.1N HCl in anhydrous isopropanol
was added to solubilize purple formazan crystals. Pipetting up and down at least 100 times
helped solubilization in dense culture situation. Absorbances at 570nm for color development
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and at 690nm for background were read using a microplate spectrophotometer (SPECTRAmax®
PLUS, Molecular Devices Co., Sunnyvale, CA). An increase or decrease of cell numbers after
exposure to a test solution would correspond to a concomitant change in the amount of purple
formazan formed or in the optical density at absorbance 570nm. The cell viability under
exposure to a test compound was expressed in %cellular mitochondrial activity, which was the
ratio of absorbance reading difference between 570nm and 690nm of test compound (A570 −
A690) to that of control (Ao570 – Ao690):
A570 − A690
%Cellular mitochondrial activity =  × 100%
Ao570 – Ao690
The lactate dehydrogenase (LDH) assay was another method used to evaluate cell
viability in terms of the degree of cell membrane integrity. It was used to detect LDH released
from both surviving and dead cells. To measure LDH released from damaged cells, 50µL/well of
the cell supernatant to be measured was transferred to a new plate and mixed with 25µL/well of a
freshly prepared LDH assay solution containing dye, along with substrate and enzyme (1:1:1).
To measure LDH in surviving cells, the cells were washed with HBSS three times to remove test
solution and a cell lysis solution (1% sodium dodecyl sulfate (SDS) in culture grade water) at
100µL/well was applied to cells for 45 minutes, followed by 50µL/well LDH assay mixture as
described above. After incubation at room temperature in the dark for 30 minutes, absorbances at
490nm for color development and at 690nm for background were read using a
spectrophotometric plate reader.
3.2.5 Cytotoxicity Studies of γ-Oryzanol, Ferulic Acid and α-Tocopherol Emulsion
Since the compounds of interest were prepared in ethanol and diluted in HBSS-emulsion
containing emulsifiers, lecithin and BSA, each one was tested for cytotoxicity. After incubation
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in any situation, the test emulsions were removed and discarded and cells were gently washed
with HBSS 3 times. MTT tests were then performed to monitor cell viability. The highest
concentrations of each test compound without cytotoxicity would be used to study its antioxidant
activity.
3.2.5.1 Cytotoxicity Studies of Emulsifiers, Lecithin and BSA
First, the cytotoxicity of emulsifiers such as lecithin and BSA that were needed to
dissolve hydrophobic compounds in aqueous solution was studied. To determine the
concentration of lecithin and BSA that could be used to prepare emulsion without affecting cell
viability, 50µL/well of each lecithin×BSA combination was added to confluent cells and
followed by 50µL/well HBSS. Final concentration of lecithin at 0, 0.05, 0.10, 0.15, 0.20 and
0.25mM and essential fatty acid free BSA at 0, 1, 3, 5, 7 and 9mg/mL were prepared in HBSS in
a 6x6 factorial design. The cells were incubated at 37oC with a humidifier tray filled with water
for 4.5 hours, followed by cell washing and MTT assay for cell viability compared to the control
(HBSS).
3.2.5.2 Cytotoxicity Studies of 2% Ethanol in Lecithin×BSA HBSS-Emulsion
Since ethanol was required to dissolve γ-oryzanol or α-tocopherol, the cytotoxicity of 2%
ethanol, which was the final concentration after diluting in HBSS-emulsion containing lecithin
and BSA, was also considered. After SVEC4-10 cells reached confluency, 100µL of 2% ethanol
in HBSS-emulsion, containing 0.25mM lecithin and 5mg/mL BSA determined previously, was
incubated with cells at 37oC for 4 or 22 hours, followed by cell washing and MTT assay, along
with HBSS or HBSS-emulsion without ethanol for comparison.

44

3.2.5.3 Cytotoxicity Studies of γ-Oryzanol, Ferulic Acid and α-Tocopherol
The purpose was to determine the maximum concentration of γ-oryzanol, ferulic acid and
α-tocopherol without affecting cell viability prior to the antioxidant activity studies. γ-Oryzanol,
α-tocopherol or ferulic acid emulsion (2% ethanol, 0.25mM lecithin and 5mg/mL BSA in HBSS)
in a serial array of concentrations up to 1.0mM was added to confluent SVEC4-10 cells
(100µL/well) for 4 or 23 hours at 37oC. The cytotoxicity of three major components of γoryzanol, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate and campesteryl ferulate was
also tested. Each one was incubated with confluent cells for 1 hour at concentrations up to 1mM
and for 22 hours at concentrations up to 0.50mM.
3.2.5.4 Cytotoxicity Studies of Interactions among γ-Oryzanol, Ferulic Acid and αTocopherol
For possible synergistic effects among γ-oryzanol, ferulic acid and α-tocopherol, an
additional set of cytotoxicity experiments for combinations was also tested. Each combination
was incubated with cells (100µL/well) at concentrations of 0.5mM γ-oryzanol+0.5mM αtocopherol, 0.5mM γ-oryzanol+0.3mM ferulic acid, 0.5mM α-tocopherol+0.3mM ferulic acid or
0.25mM γ-oryzanol+0.25mM α-tocopherol+0.2mM ferulic acid for 1 hour at 37oC or at total
concentrations up to 0.50mM of γ-oryzanol+α-tocopherol, γ-oryzanol+ferulic acid, αtocopherol+ferulic acid or γ-oryzanol+α-tocopherol+ferulic acid for 22 hours.
3.2.6 Oxidative Stress by tert-Butyl Hydroperoxide
The oxidation agent tBHP was used to cause oxidative stress in cells and the tBHP
oxidation conditions for antioxidant activity experiments depended on how long the test
emulsion was incubated with cells. Without preincubation with test solution for 22 hours, cells
were simultaneously incubated with 50µL/well of HBSS-emulsion that would be used to prepare
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each test compound (4% ethanol, 0.50mM lecithin and 10mg/mL BSA in HBSS) and 50µL/well
of tBHP in a final concentration of 0, 8, 12, 16 or 20mM in HBSS for 0, 15, 30, 45 or 60 minutes
at 37oC.
If preincubated with 100µL/well of 2% ethanol HBSS-emulsion, which would contain
each test compound later for antioxidant activity studies, for 22 hours at 37oC, after cell washing
with HBSS 3 times, cells would then be incubated with tBHP at concentrations of 0, 4, 8 or
12mM in HBSS for 0, 15, 30, 45, 60 minutes at 37oC. After the oxidation time in both
conditions, the cells were gently washed with HBSS 3 times and placed in HBSS until the
longest incubation time was concluded and ready for MTT tests, i.e. 0 oxidation time means
tBHP was added and removed immediately, washed and replaced by HBSS for 60 minutes and
15 minutes of oxidation means 15 minutes in tBHP plus 45 minutes in HBSS and so on. The
tBHP concentration that could cause significant cell death would be used for antioxidant activity
studies.
3.2.7 Studies of Antioxidant Activity and Synergism of γ-Oryzanol, Ferulic Acid and αTocopherol
Antioxidant activity, in terms of the degree of tBHP oxidative damage on mitochondria in
SVEC4-10 cells that any test compound would reduce, was expressed as %cellular mitochondrial
activity (the percentage of tBHP/HBSS of each test solution at a certain oxidation time compared
to that at 0 oxidation time or at a certain concentration compared to the control emulsion). All
experiments were conducted on confluent cells and after oxidation in any conditions, the cells
would be gently washed with HBSS three times, followed by the MTT assay to monitor cell
viability. The antioxidant activity of γ-oryzanol and ferulic acid, compared to α-tocopherol,
along with the three major components of γ-oryzanol, cycloartenyl ferulate, 24-methylene
cycloartanyl ferulate and campesteryl ferulate, and the synergistic effect among γ-oryzanol,
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ferulic acid and α-tocopherol were studied. The interferences of γ-oryzanol, α-tocopherol or
ferulic acid with tBHP or MTT were also tested.
3.2.7.1 Oxidation Time Effect on Antioxidant Activity of γ-Oryzanol, Ferulic Acid and αTocopherol
There were four conditions designed to approach the antioxidant activity. For
simultaneous presence of the test compound and tBHP, cells were incubated with 50µL/well of
each test solution (2.0mM γ-oryzanol or α-tocopherol or 1.2mM ferulic acid) and 50µL/well of
HBSS or 20mM tBHP for 0, 15, 30, 45 or 60 minutes. For pretreatment of test compound with
cells before tBHP oxidation, after being preincubated with 100µL/well of each test solution
(0.50mM γ-oryzanol, α-tocopherol or ferulic acid) for 22 hours at 37oC, cells were 1) washed
with HBSS three times and followed with 100µL/well of HBSS or 12mM tBHP for 0-60
minutes, or 2) not washed, continuously accompanied by each test solution, and 20µL/well of
HBSS or 72mM tBHP (resulting in 12mM in the 120µL/well of mixture) immediately added and
incubated for 0-60 minutes. For the effect of each test compound on tBHP oxidation before
introduction to cells, 2.0mM γ-oryzanol or α-tocopherol or 1.2mM ferulic acid was incubated
with HBSS or 40mM tBHP (1:1) in a 4-mL vial for 22 hours at 37oC and then 100µL of each
mixture was added to cells for 0-60 minutes.
3.2.7.2 Antioxidant Activity of The Three Major Components of γ-Oryzanol
The antioxidant activity of the three major components of γ-oryzanol, cycloartenyl
ferulate, 24-methylene cycloartanyl ferulate and campesteryl ferulate, at different concentrations
was investigated. After reaching confluency, SVEC4-10 cells were preincubated with
100µL/well of each test solution up to 0.50mM for 22 hours at 37oC, followed by gently washing
and 100µL/well of HBSS or 12mM tBHP for 1 hour at 37oC.
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3.2.7.3 Synergistic Antioxidant Activity of γ-Oryzanol, Ferulic Acid and α-Tocopherol
For simultaneous presence of each test compound with tBHP, cells were incubated with
50µL/well of each combination of test solution (1.0mM γ-oryzanol+1.0mM α-tocopherol,
1.0mM γ-oryzanol+0.6mM ferulic acid, 1.0mM α-tocopherol+0.6mM ferulic acid or 0.6mM γoryzanol+0.6mM α-tocopherol+0.4mM ferulic acid) and 50µL/well of HBSS or 20mM tBHP for
60 minutes. For pretreatment with the test compound, cells were preincubated with 100µL/well
of each test solution (0.25mM γ-oryzanol+0.25mM α-tocopherol, 0.25mM γ-oryzanol+0.25mM
ferulic acid, 0.25mM α-tocopherol+0.25mM ferulic acid or 0.20mM γ-oryzanol+0.20mM αtocopherol+0.20mM ferulic acid) for 22 hours at 37oC, followed with cell washing and
100µL/well of HBSS or 12mM tBHP for 60 minutes.
3.2.8 Lipid Peroxidation and Bradford Protein Assays
To measure the antioxidant activity against lipid peroxidation, two commonly used
methods, thiobarbituric acid-reactive substances (TBA-RS) method and conjugated diene
formation were performed. The TBA-RS method is to measure one of the oxidation intermediate
products, malonaldehyde, which will react with TBA and gives pink color, as an indicator of
lipid peroxidation A modified method from McDonald and Hultin (1987) was used. TBA-RS
reagent was prepared prior to use: TBA (final concentration 0.375%) was first dissolved in
0.25N HCl with heating and stirring if necessary and then trichloroacetic acid (final
concentration 15%) was added. SVEC4-10 cells for TBA-RS assay were cultured in 25-cm2
culture flasks. After reaching confluency, cells were gently washed three times with HBSS and
followed with preincubation in 8mL of 0.5mM γ-oryzanol, α-tocopherol, ferulic acid, their
combinations or each of the three major components of γ-oryzanol at 37oC for 22 hours. Each
test solution was performed independently in a culture flask. After preincubation, the test
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solution was removed, and the cells were gently washed three times with HBSS and then treated
with 8mL of HBSS or 12mM tBHP for 1 hour at 37oC. After incubation, HBSS or tBHP solution
was removed and the cells were gently washed with HBSS three times and scraped off into 1mL
of cold deionized water. Each cell suspension was transferred to a 4-mL vial and ultrasonicated
(Sonic Dismembrator, Fisher Scientific, Fair Lawn, NJ) at output 3 watts for 1 minute to
homogenize. Each test sample (750µL) or standard 1,1,3,3-tetramethoxypropane (TMP) (0, 0.05
and 0.10 µg/mL) was transferred to a 15-mL test tube with cap and mixed with 1.5mL of TBARS reagent and 50µL of 2% butylated hydroxytoluene in ethanol. The tubes were boiled for 15
minutes, cooled in running water for 10 minutes and centrifuged at 2000g for 40 minutes. The
supernatant was then transferred to acryl cuvettes to read absorbance. First, the absorption
spectrum was scanned from 350 to 800nm. The wavelength with the highest absorbance was
adjusted for background by subtracting the wavelength with lowest absorbance, which was then
used to determine concentration of TBA reactive substances in each test sample. A standard
curve was generated using TMP. The crude protein concentration in remaining cell suspension
was tested by a Bradford protein assay. The same experiment of TBA-RS and Bradford protein
assays was repeated again on a different day.
The excess TBA reactive substances produced in each sample during oxidation were
expressed in µg of TMP equivalent per gram of protein in tBHP minus that in HBSS.
Antioxidant activity of each test solution in terms of the degree of excess TBA reactive
substances prevented was compared to the control. The lower the excess TBA reactive
substances generated in a test solution during oxidation, the higher the antioxidant capacity.
Conjugated diene formation is another index for lipid peroxidation. A method modified
from Toschi et al (2000) was used. After cells were subcultured in 25-cm2 flasks and had
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reached confluency, they were preincubated with 2% ethanol in HBSS-emulsion at 37oC for 22
hours. The emulsion was then removed and cells were washed with HBSS three times and
treated with 8mL of HBSS or 12mL tBHP for 1 hour. Cells were again gently washed three times
with HBSS, scraped off into 1mL of methanol and extracted in chloroform/methanol/H2O (2:1:1)
three times. The chloroform layers were collected and combined and evaporated under nitrogen
gas. The residue of each sample was then dissolved in 500µL of acetonitrile and the absorbance
spectrum from 190 to 250nm was scanned.
For Bradford assay to measure crude cell protein, two aliquots of 5 to 10µL homogenized
cell suspension were made into 1/100 to 1/200 dilutions with deionized water and mixed with
Bradford reagent (1:1) for 5 minutes at room temperature in the dark. Similarly, the spectrum
from 350 to 800nm was scanned first to choose wavelengths for the maximum absorbance and
the background. A serial dilution of BSA at 0, 2, 4, 6µg/mL was used to construct a standard
curve (concentration versus absorbance). The crude protein concentration in each cell sample
was calculated by converting the absorbance to concentration using the standard curve and
multiplying by the proper dilution factor.
3.2.9 Experimental Design and Statistical Analysis
The experimental design for most of the cytotoxicity or antioxidant activity experiments
was a strip block design. Each test solution was randomly assigned to the columns of the plate
while each concentration of the test solution or each oxidation time was randomly assigned to the
rows of the plates. The replications were done as columns or rows whichever was available. The
test solution incubated with HBSS and tBHP were done on different plates but in the same
positions. Whole experiments were replicated on different days with different random
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assignments of test solutions and concentration levels or oxidation times. To analyze, proc mix in
SAS version 8.2 (SAS Institute Inc., Cary, NC) was used (see Appendix I for SAS codes).
3.3 Results and Discussion
3.3.1 Emulsion Preparation
Figure 3.1 shows the HPLC chromatograms of γ-oryzanol, ferulic acid and α-tocopherol.
The retention time of ferulic acid was 1.5 minutes and γ-oryzanol was 5-9 minutes and the three
major components, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate and campesteryl
ferulate were collected at 5.2-5.8, 5.8-6.3 and 6.3-6.8 minutes, respectively.
High concentration of γ-oryzanol and α-tocopherol stock solution (sterile) in ethanol
could be stored in a freezer but the concentration increased when evaporation of ethanol
occurred. Concentrations were tested by HPLC and additional filtered ethanol was added to the
stock to obtain a concentration of 50mM and the concentrations were assured by HPLC.
Otherwise, without the addition of ethanol, direct dilution from greater than 50mM stock would
result in γ-oryzanol and α-tocopherol precipitation. This may imply the importance of ethanol
acting as both solvent and emulsifier. Therefore, 2mM stock solution for cell culture experiments
were obtained by diluting 50mM in HBSS-emulsion containing 500µM lecithin and 10mg/mL
fatty acid free BSA, resulting in 4% ethanol. The stock solution higher than 2mM was difficult to
prepare because γ-oryzanol higher than 50mM was difficult to dissolve in ethanol and higher
concentration of emulsifiers, lecithin, BSA or other emulsifiers would be required. The γoryzanol and α-tocopherol emulsions were light milky color but without any suspended particles
and could be stored in a refrigerator for at least two months without precipitation.
Ultrasonication in water bath to homogenize before use was ideal.
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Figure 3.1(a). HPLC chromatogram of 0.1mM γ-oryzanol in mobile phase: methanol/acetonitrile/
dichloromethane/acetic acid (50:44:3:3) at 1.4mL/min, absorbance at 330nm
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Figure 3.1(b). HPLC chromatogram of 0.1mM ferulic acid in γ-oryzanol mobile phase: methanol/acetonitrile/
dichloromethane/acetic acid (50:44:3:3) at 1.4mL/min, absorbance at 330nm
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3.3.2 Cell Selection, Cell Viability Assay and Cell Growth Curve
Besides SVEC4-10 cells, HUV-EC-C, a normal human umbilical vein endothelial cell
line, and CPA, a normal bovine pulmonary artery endothelial cell line, were also cultured.
However, both cell lines failed to grow well and required about 2 weeks to reach confluency.
Thus, the SVEC4-10 cell line, which was available at the time, was used as a model to determine
antioxidant activity. The SVEC4-10 cell line is an endothelial cell line from axillary lymph node
vessels. The cells grow efficiently on plastic to a monolayer without the requirement of any other
exogenous growth factors or matrix components. As for the method to measure cell viability,
another assay to detect LDH released from injured cells was evaluated; however, the MTT assay
was chosen because LDH reagent reacted with α-tocopherol and gave false positive and using it
on SVEC4-10 cells showed low response signals (absorbance less than 0.1) whereas when using
MTT, the response absorbance could reach as high as 0.6.
To construct a growth curve, SVEC4-10 cells were seeded starting at 4x105cells/mL and
counted everyday for 6 days. Unlike a conventional growth curve consisting of a lag phase,
which is the time needed to recover from subculture and cell number remains the same, the cell
populations decreased during the next day after subculture (Figure 3.2). This situation commonly
occurs in some cell lines when cells recover from the stress at the beginning. Then the cell
populations increased exponentially (day1-4), the log phase, until reaching the plateau phase, in
which the cells reached confluency to form a monolayer and the cell growth slows down due to
the limited nutrition and generated wastes (day4-5). However, some tumor cells, as in this case,
can later accumulated and continue to grow for a few more days. To maintain a cell line, it would
be preferable for the next passage at the end of the log phase to yield healthy and consistent cell
cultures with good reproducibility. Therefore, to maintain consistency for further experiments,
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Figure 3.2. Growth curve of SVEC4-10 cells starting at
4×105 cells/mL after subculture (data shown
were duplicates)
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the SVEC4-10 cells were always plated at 4x105cells/mL and used for antioxidant activity
studies at the 3rd to 4th day, when they had reached confluency.
3.3.3 Cytotoxicity Studies of γ-Oryzanol, Ferulic Acid and α-Tocopherol Emulsion
3.3.3.1 Cytotoxicity Studies of Emulsifiers and Ethanol
Results in Figure 3.3 show that, statistically, there was a lecithin concentration main
effect and a BSA concentration main effect but no interaction between lecithin and BSA.
However, each concentration of BSA (1, 3, 5 or 7 mg/mL), regardless of the lecithin effect, and
each concentration of lecithin (0.05, 0.1, 0.15 or 0.2mM), regardless of the BSA effect, were not
significantly different from the control (HBSS) when incubated with cells for 4.5 hours. There
was also no significant difference between each of the 36 lecithin and BSA (6×6) combinations
and the control, including the mixture of 0.25mM lecithin and 5mg/mL BSA in HBSS, which
was used to prepare the emulsion of γ-oryzanol, α-tocopherol or ferulic acid in the later studies.
Since ethanol was one of the few solvents that could be used to dissolve γ-oryzanol, αtocopherol or ferulic acid and was used for cell culture experiments, the effect of 2% ethanol in
HBSS emulsion with 0.25mM lecithin and 5mg/mL BSA was studied. The results showed that,
the cellular mitochondrial activity (93.03%) was not significantly different from the control
(HBSS) (100%), when 2% ethanol HBSS-emulsion was incubated with SVEC4-10 cells for 4
hours (Figure 3.4(a)), while it significantly decreased to 77.02% when incubated for 22 hours
(p<0.05) (Figure 3.4(b)). Even though SVEC4-10 cells were more susceptible to 2% ethanol, it
was necessary to use ethanol due to the difficulty in dissolving γ-oryzanol and α-tocopherol in
aqueous culture solution. Therefore, in the further experiments, 2% ethanol in HBSS emulsion
was always performed and referred to as the control for comparison.
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Figure 3.3. Cytotoxicity study of emulsifiers, lecithin and fatty acid
free BSA incubated with SVEC4-10 cells for 4.5 hours
at 37oC
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3.3.3.2 Cytotoxicity Studies of γ-Oryzanol, Ferulic Acid and α-Tocopherol
First of all, the results did not show any false positives between γ-oryzanol, ferulic acid or
α-tocopherol and MTT reagent, which means γ-oryzanol, ferulic acid or α-tocopherol if present
would not interfere with the MTT assay. The cytotoxicity results showed that when incubated
with SVEC4-10 cells for four hours, the effects of γ-oryzanol, ferulic acid and α-tocopherol on
cellular mitochondrial activity were not all the same when averaged out for concentration effect
(Figure 3.5(a)). γ-Oryzanol and α-tocopherol concentrations up to 1.0mM did not decrease
cellular mitochondrial activity significantly while ferulic acid at 0.8 and 1.0mM did (p<0.05).
Therefore, the highest concentrations of γ-oryzanol and α-tocopherol studied for their
antioxidant activity would not exceed 1.0mM and 0.6mM for ferulic acid.
The results in Figure 3.5(b) showed that when incubated with cells for 22 hours, γoryzanol, ferulic acid and α-tocopherol up to 1.0mM did not decrease cell viability significantly.
There was no concentration effect when averaged out for the effect of the type of test compound.
However, to be conservative due to the fact that the overnight preincubation may be a stress to
cells, 0.5mM was the highest concentration of γ-oryzanol, ferulic acid or α-tocopherol tested for
their antioxidant activity.
Additionally, since the three major components of γ-oryzanol make up about 70-80% of
total γ-oryzanol, the cytotoxicity of the three pure compounds was also tested. Each of the
components up to 1.0mM was incubated with cells for 1 hour and up to 0.5mM for 22 hours. The
results showed that incubation time of 1 hour did not significantly decrease %cellular
mitochondrial activity (Figure 3.6(a)) and up to 1.0mM of each compound incubated with cells
for 1 hour would later be studied for antioxidant activity. The results also showed that the
incubation time of 22 hours did not cause cell death, except for 0.5mM campesteryl ferulate
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(Figure 3.6(b)). Therefore, 0.5mM of each component would be the highest concentration
studied for their antioxidant activity, except that 0.25mM was used for campesteryl ferulate, if
incubated with cells for 22 hours.
3.3.3.3 Cytotoxicity Studies of Interactions among γ-Oryzanol, Ferulic Acid and αTocopherol
The

cytotoxicity

of

0.50mM

γ-oryzanol+0.50mM

α-tocopherol,

0.50mM

γ-

oryzanol+0.30mM ferulic acid, 0.50mM α-tocopherol+0.30mM ferulic acid or 0.25mM γoryzanol+0.25mM α-tocopherol+0.20mM ferulic acid incubated with cells for 1 hour was
studied and the result showed that no combinations diminished cell viability differently from the
control (2% ethanol HBSS-emulsion) (Figure 3.7(a)). There was no effect of concentration levels
regardless of type of test solution. Thus, the synergistic antioxidant activity among these test
compounds at these concentration levels under this condition would be evaluated.
When incubated with cells for 22 hours, however, the results showed that γoryzanol+ferulic acid and α-tocopherol+ferulic acid at all concentrations significantly decreased
cell growth compared to the control (Figure 3.7(b)). Therefore, only the synergistic antioxidant
activity of γ-oryzanol+α-tocopherol would be further studied.
3.3.4 The Effects of tBHP Concentration and Oxidation Time on SVEC4-10 Cellular
Mitochondrial Activity
When cells were not preincubated with 2% ethanol HBSS-emulsion, statistically there
were effects due to tBHP concentration, oxidation time and also concentration and time
dependent interactions (Figure 3.8(a)). Regardless of the incubation time, 20mM of tBHP caused
greater reduction in cellular mitochondrial activity than that caused by other levels of tBHP.
Regardless of the concentration effect, oxidation for 60 minutes resulted in the greatest reduction
among other shorter oxidation times. Furthermore, tBHP concentration of 12-20mM for 30-60
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minutes could significantly reduce cell viability compared to the control (p<0.05), but only
20mM injured cells significantly compared to any concentration level at any incubation time
level. Thus, for further antioxidant activity experiments, tBHP oxidation conditions for SVEC410 cells without preincubation would be 20mM for 60 minutes.
For SVEC4-10 cells preincubated with test emulsions overnight, the oxidation conditions
varied. Less oxidation for preincubated cells was needed to induce the same amount of cell
injury. The results (Figure 3.8(b)) indicated that statistically there was no tBHP concentration
effect, which indicates that with the oxidation time effect averaged out, there was no significant
differences among any concentration level. However, overall there was an oxidation time effect
(15-60 minutes in tBHP, regardless of concentration, significantly impaired cell viability
compared to the control (HBSS) (p<0.05)). There was also an interaction effect between
concentration and time (p<0.05). A tBHP concentration of 12mM at oxidation time of 60
minutes decreased cellular mitochondrial activity to a greater extent compared to any
concentration level (p<0.05) but not at any time shorter than 45 minutes. Therefore, 12mM tBHP
for 60 minutes was used later to study antioxidant activities of γ-oryzanol, ferulic acid and the
three major components of γ-oryzanol compared to α-tocopherol which were preincubated with
cells overnight.
There was an interesting characteristic of SVEC4-10 cell growth: when comparing the
two formats (preincubation or not), cells seemed to revive more completely in response to
oxidative stress after preincubation. Without oxidative stress, the cells grew significantly over
time, which may mean that SVEC4-10 cells had a rapid metabolism, especially after
preincubation with HBSS-emulsion. It has been reported that tBHP at very low concentration
(10-5mM) could actually stimulate cell growth on polyoma virus transformed baby hamster
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fibroblasts and corresponding non-transformed cells (Burdon and Gill, 1989). The reason may be
relevant to the inflammatory response to tissue replenishment following tissue damage due to
oxidative stress. However, the tBHP concentrations used here to induce oxidative damage were
much higher. More research is needed to further understand the mechanism of tBHP
cytotoxicity. These results also provided another reason to always do HBSS experiments, in
addition to tBHP, in order to compare tBHP/HBSS ratio to that of the control at 0 time.
These oxidation results may also imply that the oxidation conditions are critical in
antioxidant activity studies. If the oxidation is not strong or long enough, the differences in cell
viability between the treated and control may be too subtle to be detected. Also, if the oxidation
is too strong or too long, the excess tBHP may damage all cells. In either situation small but real
differences between each antioxidant activity could not be determined.
3.3.5 Antioxidant Activity and Possible Synergism of γ-Oryzanol, Ferulic Acid and αTocopherol
3.3.5.1 Antioxidant Activity of γ-Oryzanol, Ferulic Acid and α-Tocopherol at Different
tBHP Oxidation Time
Antioxidant activity of γ-oryzanol, ferulic acid and α-tocopherol was determined relative
to the effectiveness in preventing tBHP oxidative damage for 0, 15, 30, 45 or 60 minutes on
mitochondria in SVEC4-10 cells. When γ-oryzanol, ferulic acid or α-tocopherol was
simultaneously present with tBHP for 1 hour, the results (Figure 3.9(a) and Appendix II(a))
showed that the overall effect of γ-oryzanol, ferulic acid or α-tocopherol on reducing tBHP
damage in cells, regardless of the oxidation time, was not significantly different from the control
(2% ethanol HBSS-emulsion). There was a significant oxidation time main effect (p<0.05),
which means that the cell viability at each tBHP incubation time was different from each other
being the highest at 0 minute and lowest at 60 minutes. There was no overall interaction between
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the test solution and the oxidation time. All the test solutions were not significantly different
from the control at oxidation time of 15, 30 or 45 minutes. Hence, it may imply that if present
with tBHP simultaneously for 1 hour, γ-oryzanol, ferulic acid or α-tocopherol had no significant
effect on preventing tBHP oxidative damage in cells.
When the cells were preincubated with γ-oryzanol, ferulic acid or α-tocopherol for 22
hours, washed and then oxidized by tBHP, the results showed that the type of test solution main
effect was not significant, but the oxidation time main effect and the interaction of
type×oxidation time were significant (p<0.05) (Figure 3.9(b) and Appendix II(b)). When the
oxidation time effect was averaged out, the cellular mitochondrial activity of any test solution
was significantly greater than that of the control (p<0.05). When the test solution effect was
averaged out, the effect of tBHP oxidation time at 60 minutes was significantly the greatest
(p<0.05) but at 15 or 30 minutes was not significant. Statistically, if there is no interaction, the
differences of antioxidant activity between any two test solutions should remain the same at any
oxidation time. In this case, there was an interaction between the type of test solution and the
oxidation time indicating that the test solution that had higher antioxidant activity at shorter time
of oxidation was not always higher at longer time of oxidation and vice versa. At 15 and 30
minutes of oxidation, 0.50mM ferulic acid had the greatest antioxidant activity but had the
lowest at 60 minutes. On the other hand, γ-oryzanol and α-tocopherol had an antioxidant activity
not greater than ferulic acid at the early stage of incubation time but greater at the later stage.
Therefore, it might imply that γ-oryzanol, ferulic acid and α-tocopherol all were associated with
cells in some way and further protected cells from tBHP oxidative damage.
When γ-oryzanol, ferulic acid or α-tocopherol were preincubated with cells for 22 hours
without washing, the results (Figure 3.9(c) and Appendix II(c)) showed that the type of test
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solution main effect was not significant, but the oxidation time main effect and interaction of test
type×oxidation time on cell viability were significant (p<0.05). Oxidation time longer than 30
minutes was significantly different from 0 time (p<0.05), regardless of the type of the test
solution. Similarly, the antioxidant activity of the control (2% ethanol HBSS-emulsion) was the
lowest at any oxidation time. Ferulic acid had the greatest antioxidant activity, but was not
significantly different from γ-oryzanol and α-tocopherol, at the oxidation time of 15 and 30
minutes while α-tocopherol and γ-oryzanol had a greater antioxidant activity at oxidation times
of 45 and 60 minutes, respectively. It may be suggested that the antioxidant activity of γoryzanol, ferulic acid and α-tocopherol can extend to a greater degree if associated with the cells
for 22 hours and continue to protect cells from tBHP oxidation. Also, ferulic acid may play a
more important role in preventing tBHP damage at the early stage, then α-tocopherol and then γoryzanol later.
Finally, when test compounds were reacted with tBHP for 22 hours before being
introduced to cells, the results (Figure 3.9(d) and Appendix II(d)) showed that there was a
significant oxidation time main effect (p<0.05) and an interaction effect (p<0.05) but no test
solution main effect. Regardless of the type of test solution, oxidation at any time was
significantly higher than 0 time. Also, regardless of the oxidation time effect, γ-oryzanol, αtocopherol and ferulic acid did not have an antioxidant activity significantly different from the
control. These relationships held true at most oxidation times.
Thus, it may be suggested that the antioxidant activity mechanisms of γ-oryzanol, ferulic
acid and α-tocopherol are different. When exposed to tBHP before cells, γ-oryzanol or ferulic
acid had lower antioxidant activity than α-tocopherol. But when associated with cells, γ-oryzanol
and ferulic acid can be more effective than α-tocopherol in preventing cell death. Thus, it may be
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speculated that association with cells, probably on the cell membrane, is necessary for γ-oryzanol
and ferulic acid to protect cells from tBHP oxidation. Comparing the chemical structure of γoryzanol with ferulic acid, the presence of the sterol or triterpene alcohol part in γ-oryzanol
seems to alter the antioxidant activity of ferulic acid because γ-oryzanol did not always show
higher antioxidant activity than ferulic acid.
3.3.5.2 Antioxidant Activity of The Three Major Components of γ-Oryzanol
As for the three major components of γ-oryzanol, cycloartenyl ferulate, 24-methylene
cycloartanyl ferulate and campesteryl ferulate, their antioxidant activity was also compared to αtocopherol at different concentrations (0.05 to 0.5mM) by preincubation with the cells for 22
hours, followed by cell washing and 12mM tBHP oxidation for 1 hour. The results (Figure 3.10
and Appendix II(e)) showed that, neither the type of test solution main effect nor the
concentration main effect was significant, but there was a significant interaction between the
type of the test solution and the concentration level (p<0.05). At each of concentration levels
from 0.05 to 0.25mM, α-tocopherol tended to have an antioxidant activity higher than the control
but not significantly (p=0.2786, 0.1901 and 0.0784, respectively), except at 0.5mM where 24methylene cycloartanyl ferulate was the greatest and significantly greater than the control
(p<0.05). It may be suggested that α-tocopherol is an effective antioxidant even at concentrations
as low as 0.05mM. On the other hand, γ-oryzanol did not have significant antioxidant activity at
each concentration level tested but there was a trend towards increased activity in a
concentration-dependent manner. Although not significant, cycloartenyl ferulate and campesteryl
ferulate at a concentration higher than 0.1mM tended to have a higher antioxidant activity than
the control. At the lower concentration, the antioxidant activity of 24-methylene cycloartanyl
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ferulate was not higher than cycloartenyl ferulate but was significantly higher at a concentration
of 0.5mM (p<0.05).
The three major components all prevented tBHP oxidative damage in SVEC4-10 cells to
a degree greater than γ-oryzanol. In another study, the three major components of γ-oryzanol
were found to be more effective than γ-oryzanol in their inhibitory effect on 12-otetradecanoylphorbol-13-acetate-induced inflammation in mouse skin (Yasukawa et al., 1998).
More research on whether or not the anti-inflammatory effect is related to their antioxidant
activity is needed. Since the three components constitute about 70-80% of total γ-oryzanol, it
may be suggested that these three components may be more responsible for the antioxidant
activity of γ-oryzanol than other minor components.
The antioxidant mechanism of ferulic acid has been evidenced from its potential of
radical scavenging ability (Graf, 1992). Ferulic acid can form a phenoxy radical by donating a
hydrogen atom to any reactive radical. The unpaired electron of ferulic acid radical can be
delocalized across the entire molecule and thus becomes resonance stabilized. By comparing
antioxidant activity and chemical structures, all of the γ-oryzanol components have the phenolic
hydroxyl group in the ferulate portion, which can be a peroxyl-radical scavenger. In addition, 24methylene cycloartanyl ferulate has a methylene group at C-24 position attached to two alkyl
groups while cycloartenyl ferulate has an alkene on C-24. The presence and the position of the
double bond in the side chain of the terpene alcohol may also be related to its antioxidant
activity.
24-Methylene cycloartanyl ferulate exhibiting a higher antioxidant activity than the other
two components of γ-oryzanol and α-tocopherol was also observed in preventing cholesterol
oxidation induced by 2,2’-azobis(2-methylpropionamidine) dihydrochloride (Xu et al., 2001).
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This may suggest that among the components of γ-oryzanol, 24-methylene cycloartanyl ferulate
had a higher antioxidant activity than the other components and, given a high enough
concentration, it can even be more effective than α-tocopherol in preventing SVEC4-10 cell
damage.
3.3.5.3 Synergistic Antioxidant Activity of γ-Oryzanol, Ferulic Acid and α-Tocopherol
When simultaneously present with tBHP and cells for 1 hour, the combination of γoryzanol+α-tocopherol+ferulic acid (at concentration of 0.33mM, 0.33mM and 0.2mM,
respectively) decreased the tBHP damage to cells, compared to the control, or 1.0mM γ-oryzanol
or 0.6mM ferulic acid alone (p<0.05) or 1.0mM α-tocopherol (p=0.1158) (Figure 3.11(a) and
Appendix II(a)). When preincubated with cells for 22 hours, even though not significant, the
combination of 0.25mM γ-oryzanol+0.25mM α-tocopherol tended to have higher antioxidant
activity than the control (p=0.1747), 0.50mM γ-oryzanol alone (p=0.3463) or 0.50mM αtocopherol alone (p=0.7170) (Figure 3.11(b) and Appendix II(b)).
Based on these results, it may be suggested that a synergistic antioxidant activity of γoryzanol or ferulic acid with α-tocopherol possibly exists. α-Tocopherol has been studied
extensively and is known for its function to inhibit lipid peroxidation by scavenging lipid peroxyl
radicals to yield lipid hydroperoxides and a tocopheroxyl radical (Diplock et al., 1998). The
tocopheroxyl radical is less reactive and acts as a chain-breaking antioxidant. Tocopherol can be
regenerated from the tocopheroxyl radical by ascorbic acid and glutathione. The synergistic
effect of ascorbic acid on antioxidant activity of α-tocopherol was found to regenerate αtocopherol because the ascorbyl radical not the tocopheroxyl radical was detected (Scarpa et al.,
1984). Therefore, it can be postulated that the synergistic antioxidant activity among γ-oryzanol,
ferulic acid and α-tocopherol may be due to 1) the regeneration of α-tocopherol by γ-oryzanol
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Figure 3.11(a). Synergistic antioxidant activity of γ-oryzanol, ferulic
acid and α-tocopherol simultaneously incubated with
cells and tBHP for 1 hour. Significant differences (p<0.05)
are expressed by different letters.
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Figure 3.11(b). Synergistic antioxidant activity of γ-oryzanol, ferulic
acid and α-tocopherol preincubated with cells for 22 hours
then added tBHP oxidation for 1 hour. Significant differences
(p<0.05) are expressed by different letters.
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and/or ferulic acid, 2) γ-oryzanol and/or ferulic acid spares α-tocopherol from radicals by
quenching them, or 3) vice versa. Further investigation is required to understand the synergistic
antioxidant mechanisms of γ-oryzanol, to identify the oxidized γ-oryzanol products and to
develop the analytical method to detect them.
In a cell model using cells with fast metabolism such as SVEC4-10 cells, the cell viability
is dynamic even in the control situation for a relatively short period of time, not to mention when
incubated with any test substance and HBSS for a longer time, thus the cell viability can vary
widely. These studies also support the approach to interpret cellular mitochondrial activity as a
percentage of treated (tBHP) over control (HBSS) and compares it to that of 2% ethanol HBSSemulsion at 0 treatment time. This mathematical adjustment may not be ideal but is fairly
reasonable.
3.3.6 Lipid Peroxidation Assays
For the TBA-RS results, measuring the absorbances of the color products in standards
and samples is recommended to scan absorbance spectrums for both standards and samples in
every assay because the wavelengths for maximum absorbances can vary. Figure 3.12 showed
that the maximum absorbance for TMP as standard was at 520nm but it was at 440-450nm for
samples. The wavelength at 600nm was used to assess background interference in both standards
and samples. The aim in this method would be to detect all substances reactive with TBA, which
include not only malonaldehyde that produces a red pigment (at 520nm) but also alkanals,
alkenals and 2,4-dienals that produce a yellow pigment (at 450nm). It has been suggested that it
may be appropriate to measure both absorbances (Nawar, 1996). Thus, it may imply low
specificity of this method.
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Figure 3.12. Spectrum scan from 350 to 610nm for (a) standard TMP
(0.1µg/mL) and (b) TBA-reactive substances in cell
samples treated with tBHP
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The Bradford protein assay using Coomassie blue is the most widely used method and is
commercially available as a kit. It measures protein content of cells to estimate total cellular
material, which is often used as a denominator in expressions of, in this case, TBS-RS
concentrations. It does not measure specific amino acids but is quite convenient. The maximum
absorbances for BSA standards and samples were in a range from 595 to 640nm and absorbance
at 790nm was used to assess background interference. Using SDS to solubilize protein or cells
was not recommended because it could react with Bradford reagent.
When the SVEC4-10 cells were preincubated with γ-oryzanol, ferulic acid, α-tocopherol,
their combinations or the three major components of γ-oryzanol for 22 hours and then washed
and treated with HBSS or tBHP for 1 hour, the results in terms of excess TBA-RS produced
during oxidation per unit protein showed that there was no significant difference among these
test compounds and the control (2% ethanol in HBSS-emulsion) (Figure 3.13). Even though the
same test solutions in the same conditions were studied for their effect on preventing cellular
mitochondrial damage from tBHP oxidation, the results were found to lack agreement between
them. Similar to this case, it also has been reported that some antioxidants can reduce TBA-RS
formation but did not preserve cell viability (Rush et al., 1985). The cytotoxicity of tBHP has
been studied and postulated that lipid peroxidation may not be the main mechanism of tBHP
cytotoxicity (Buc-Calderon et al., 1991).
However, in this study the standard error for each test compound was relatively large,
which implied poor reproductivity of this method. Furthermore, this method could not measure
the TBA-RS released to solution during tBHP oxidation. Test solutions were always removed
and cells were washed before testing because tBHP could react with TBA-RS reagent and give
false positives.
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Figure 3.13. TBA-RS assay for antioxidant activity of γ-oryzanol,
ferulic acid, α-tocopherol, their combinations and
three γ-oryzanol major components preincubated with
SVEC4-10 cells for 22 hours which were later treated
with HBSS or 12mM tBHP for 1 hour. Significant
differences (p<0.05) are expressed by different letters.
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There were many disadvantages to the use of this TBA-RS method to study antioxidant
activity of the compounds of interest, including poor reproductivity, low specificity and they are
time and labor consuming. In addition, these TBA-RS experiments were scaled up using 8mL of
each test solution and cells grown on 25cm2 surface area flasks (equivalent to 100µL to surface
area of a well in a 96-well plate), in order to amplify the response signals. Nevertheless, the
results did not show any significance. Therefore, it is very difficult to draw conclusions without
further investigation.
Another index of lipid peroxidation, conjugated diene formation, was also studied.
However, the results showed that there was no peak detected at 234nm even in cells incubated
with tBHP under conditions that would cause a marked decrease in cellular mitochondrial
activity (Figure 3.14). Detecting lipid peroxidation has been known to be difficult due to the
transient nature of lipid hydroperoxides and their decomposition (Aust, 1985). Therefore, it was
not possible to distinguish the antioxidant activity of γ-oryzanol on lipid oxidation by introducing
this method to the cell model developed for this study and whether or not the antioxidant activity
of γ-oryzanol was responsible for preventing lipid peroxidation in cells was not delineated. A
search in the future for other methods to approach this issue is necessary.
3.4 Conclusion
In this study, a cell model using SVEC4-10 mouse lymph endothelial cells, tBHP as
oxidant agent and MTT for cell viability measurement was established and proven to be capable
of distinguishing antioxidant activity of γ-oryzanol, ferulic acid, the three major components of
γ-oryzanol, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate and campesteryl ferulate,
from α-tocopherol. It was found that the SVEC4-10 cell line had a fast metabolism and
consequently could be used to determine antioxidant activity of a test substance in a relatively
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Figure 3.14. Spectrum scan from 190 to 250nm for conjugated diene
formation from chloroform/methanol/H2O extraction of
SVEC4-10 cells treated with (a) HBSS or (b) tBHP
oxidation for 1 hour

82

rapid manner. The critical and vital parameters relied on were 1) the emulsion preparation of
hydrophobic compounds for cell model, 2) the consistent management of cell culture ready for
antioxidant activity experiments, 3) the control of tBHP oxidation conditions such as
concentration and time combinations and 4) the selection of cell viability detection methods
compatible with the cell line and the test substances.
In summary, γ-oryzanol and ferulic acid did possess antioxidant activity, in terms of
preventing cellular mitochondrial damage due to tBHP oxidation. When preincubated with the
SVEC4-10 cells, ferulic acid had higher antioxidant activity than γ-oryzanol and α-tocopherol at
the early stage of oxidation (0 to 30 minutes) while γ-oryzanol and α-tocopherol tended to have
higher antioxidant activity than ferulic acid at the late stage of oxidation (30 to 60 minutes). The
three major components of γ-oryzanol generally had higher antioxidant activity than γ-oryzanol
and in some situations presented more effective antioxidant activity than α-tocopherol. Among
these three major components of γ-oryzanol, 24-methylene cycloartanyl ferulate was found to be
relatively more effective. A synergistic antioxidant activity among γ-oryzanol, ferulic acid and
α-tocopherol was also found when simultaneously present with tBHP for one hour.
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CHAPTER 4. HYPOCHOLESTEROLEMIC CAPACITY EXPERIMENTS USING AN IN
VITRO HUMAN INTESTINAL CELL MODEL
4.1 Introduction
Another potential functionality of γ-oryzanol, hypocholesterolemic capacity, has been
reported in a range of human and animal studies including rats and monkeys, which showed
promising results for γ-oryzanol in reducing serum total, free, esterified and liver cholesterol
levels. This research is the first attempt to develop an in vitro cell model using human intestinal
cells and use it to demonstrate the possible mechanisms of hypocholesterolemic capacity of γoryzanol.
Since the digestive, absorptive and metabolic fate of γ-oryzanol is not clearly delineated
and in view of the γ-oryzanol effect on enhancing cholesterol excretion, the potential mechanism
by which γ-oryzanol decreases cholesterol uptake may be related to its action in the lumen of the
gastrointestinal tract. In the human intestines, there are two sources of cholesterol. Typically onethird comes from diet (exogenous source) and the remaining two-thirds from bile (endogenous
source). It has been demonstrated that decreasing cholesterol uptake can lead to decreasing
serum cholesterol. Therefore, this study focused on γ-oryzanol effects in the intestines to
decrease cholesterol uptake.
In order to approach this goal, one objective of this study was to develop an in vitro cell
model using a human intestinal cell line to study cholesterol uptake and use a gas
chromatography (GC) coupled with mass spectrometry (MS) to analyze cholesterol. In addition,
since dietary cholesterol consists of two forms, free and esterified, the γ-oryzanol effect on the
stability of micelles containing both forms of cholesterol or the availability of total cholesterol
for uptake would be studied. Finally, the pancreatic enzymes, cholesterol esterase (CEase) and
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phospholipase A2, present in the intestines have been reported to promote cholesterol uptake
(Mackay et al., 1997) and CEase is also responsible for hydrolyzing cholesteryl esters.
Therefore, the possibility that γ-oryzanol inhibits or otherwise interferes with the activity of these
enzymes would also be investigated.
4.2 Materials and Methods
4.2.1 Materials and Reagents
γ-Oryzanol was obtained from crude rice bran oil using a preparative normal-phase high
performance liquid chromatography (HPLC) and crude rice bran oil was extracted from milled
rice bran according to the method developed by Xu and Godber (1999). The preparative HPLC
system consisted of a Waters (Milford, MA) Prepak® RCM base connected with two cartridges
(each 25mm×10cm Prep Nova-Pak HR silica with particle size 6µm) and a Guard-Pak insert, a
U6K manual injector, a 510 pump and a Lambda-Max 481 LC Spectrophotometer (wavelength
330 nm). Mobile phase was methanol with a constant flow rate at 15 mL/min and 2mL of the
crude oil were injected each time. The eluate containing γ-oryzanol was collected (25-30min)
and the solvent was evaporated.
Cholesterol, cholesteryl oleate, oleic acid, 1-monoolein, lecithin, sodium taurocholate,
MTT assay kit, Bradford reagent, Hank’s balanced salts, porcine pancreatic cholesterol esterase,
phospholipase A2 and trimethylsilylation reagents (N,O-bis(trimethylsilyl)trifluoroacetamide and
trimethylchlorosilane

(99:1))

were

purchased

from

Sigma,

St.

Louis,

MO.

Tris(hydroxymethyl)aminomethane was purchased from Amresco, Solon, OH. HCl was
purchased from Mallinckrodt, Inc., Paris, KY. NaOH, hexane and isopropanol were purchased
from Fisher Scientific, Fair Lawn, NJ. Ethanol was USP absolute 200 proof purchased from
AAPER Alcohol and Chemical Co., Shelbyville, KY. Culture plates were purchased from
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Corning Inc., Corning, NY, and the sterile disposable syringe filter was 0.2µm PES purchased
from Whatman, Clifton, NJ.
Tris-HCl

buffer

(0.1M)

was

prepared

by

dissolving

1.2114g

of

Tris(hydroxymethyl)aminomethane in about 90mL of distilled deionized water, adjusting pH to
7.5 with 10N of HCl and diluting to 100mL volume with water.
4.2.2 Micelle Preparation
A modified method from Nagaoka et al., (1999), was used to prepare micelles containing
cholesterol, cholesteryl oleate and/or γ-oryzanol in aqueous solutions. Cholesterol or cholesteryl
oleate at a concentration of 0.2mM with or without 0.2mM γ-oryzanol was dissolved in
hexane:isopropanol (3:1) with 1mM oleic acid, 0.5mM 1-monoolein and 0.6mM lecithin (final
concentration). The solvent was evaporated using a vacuum evaporator (45oC, CentriVap
Console, Labconco Inc., Kansas City, MO) and then 6.6mM sodium taurocholate in buffer or
culture medium was added. Each solution was ultrasonicated (Sonic Dismembrator, Fisher
Scientific, Fair Lawn, NJ) at output power of 10 watts for 45 minutes in an ice bath in order to
ensure a clear solution free of precipitation. For cell culture experiments, micellar solutions were
filtered through a 0.2µm filter for sterilization before being applied to cells. The cholesterol and
cholesteryl oleate concentrations in the filtrate were later extracted and determined by GC/MS to
ensure that cholesterol or cholesteryl oleate did not precipitate and that the micelle formation was
successful.
4.2.3 Effect of γ-Oryzanol on Micellar Solubility of Cholesterol and Cholesteryl Oleate
Cholesterol and cholesteryl oleate solubility in micelles with γ-oryzanol was measured by
adding 10µL of ethanol or 10mM γ-oryzanol in ethanol to 990µL of 0.1mM of cholesterol or
cholesteryl oleate micellar solution (final γ-oryzanol concentration was 0.1mM and ethanol was
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1%). The mixture was vortexed, incubated in a shaking water bath at 37oC for 24 hours and then
ultracentrifuged (Beckman TL100 Ultracentrifuge, Beckman Instruments, Inc., Palo Alto, CA) at
100,000×g at 37oC for 1 hour. The supernatant (500µL) was extracted to determine the γoryzanol concentration by HPLC. The remaining samples were dried under vacuum for
cholesterol or cholesteryl oleate analysis by GC/MS.
4.2.4 Study of γ-Oryzanol Inhibition on CEase-Facilitated Cholesteryl Oleate Hydrolysis
To study γ-oryzanol effect on CEase-facilitated cholesteryl oleate hydrolysis, first of all,
the relationship between the substrate (cholesteryl oleate) concentration and the hydrolytic
enzyme (CEase) concentration had to be determined since it could affect the reaction rate, by
which an understanding of the enzyme kinetics and the possible inhibition mechanism by γoryzanol could be obtained. Cholesteryl oleate micellar solution (1mL of 0.2mM in 0.1M TrisHCl buffer, pH 7.5) was incubated with a serial of concentrations of CEase from 0, 0.003, 0.03
to 30µg protein/mL in a shaking water bath at 37oC for 5 minutes. After incubation, solvent
extraction was immediately performed, followed by GC/MS to determine the concentration of
cholesterol released from hydrolysis. The lowest CEase concentration that could result in a
detectable amount of cholesterol significantly different from the control emulsion without CEase
would be used to study the γ-oryzanol effect on CEase activity.
To study γ-oryzanol effect on CEase inhibition, 1mL micellar solution containing
cholesteryl oleate at concentrations of 0.05, 0.2 or 2mM with or without 0.1mM γ-oryzanol was
incubated with CEase at 37oC for 5 minutes, immediately followed by solvent extraction and
GC/MS determination of the amount of cholesterol released. The results would be expressed in a
Michaelis-Menten plot (initial reaction rate versus substrate concentration) and a doublereciprocal, or Lineweaver-Burk, plot (reciprocal of initial reaction rate versus reciprocal of
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substrate concentration). To determine the type of inhibition, if present, and the SAS system
(version 8.2, SAS institute, Cary, NC) was used to compare the regression curve of the with γoryzanol effect to the without γ-oryzanol curve.
4.2.5 Cholesterol Uptake by Human Intestinal Cells In Vitro
4.2.5.1 Cell Culture
Human large intestinal cell line C2BBe1 (ATCC CRL-2102) was used to study
cholesterol uptake. The cell line was maintained in 25-cm2 flasks with vent caps. To subculture,
cells were washed three times using 0.25% trypsin (1mL each time). On the third time cells were
kept in the trypsin solution for 10 minutes at 37oC. After cells detached, new medium (90%
DMEM with 4mM L-glutamine, 1.5g/L sodium bicarbonate and 4.5g/L glucose and
supplemented with 0.01mg/mL human transferrin; 10% fetal bovine serum) was added and the
cell suspension was split into new 25-cm2 flasks (split ratio 1:3). For cholesterol uptake
experiments, the cell suspension was diluted in new medium to 2x105 cells/mL and 1mL was
transferred to each well (area=2cm2) of the 24-well culture plates, which resulted in 105cells/cm2.
For cytotoxicity studies, 96-well plates were used and 100µL of the cell suspension was cultured
in each well. Cell count was performed at each subculture to ensure consistency for each
experiment. Cells were used for experiments when they reached confluency (about the 4th day
after subculture).
4.2.5.2 Cytotoxicity Studies of Micellar Solutions Using an MTT Assay
Before being applied to the cells for the study of cholesterol uptake, all micellar solutions
were investigated for their cytotoxicity. After reaching confluency in 96-well culture plates, the
cells were gently washed using Hank’s balanced salt solution (HBSS) twice and 100µL/well of
each test solution was applied for 2 hours at 37oC. After incubation, the test solutions were
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discarded and the cells were gently washed again using HBSS, followed by a 3-(4,5dimethylthiazol-yl)-2-5-diphenyltetrazolium bromide (MTT) assay to measure cell viability in
terms of the activity of mitochondrial dehydrogenases in living cells. The cells were incubated
with 40µL/well of 1.25mg/mL MTT in HBSS, which is yellow in color, at 37oC in the dark for 2
hours. The mitochondrial dehydrogenases of viable cells cleaved the tetrazolium ring and yielded
purple formazan crystals, which are insoluble in aqueous solution. Then 100µL/well of MTT
solubilization solution containing 10% Triton X-100 plus 0.1N HCl in anhydrous isopropanol
was added to solubilize purple formazan crystals. Pipetting up and down at least 100 times
helped solubilization in dense culture situation. Absorbances at 570nm for color development
and at 690nm for background were read using a microplate spectrophotometer (SPECTRAmax®
PLUS, Molecular Devices Co., Sunnyvale, CA). An increase or decrease of cell numbers after
exposure to a test solution would correspond to a concomitant change in the amount of purple
formazan formed or in the optical density at absorbance 570nm. The cell viability under
exposure to a test compound was expressed in %cellular mitochondrial activity, which was the
ratio of absorbance reading difference between 570nm and 690nm of test compound (A570 −
A690) to that of the control (Ao570 – Ao690):
A570 − A690
%Cellular mitochondrial activity =  × 100%
Ao570 – Ao690
4.2.5.3 Study of Cholesterol Esterase or Phospholipase A2-Promoted Cholesterol Uptake by
Human Intestinal Cells In Vitro
First of all, the cytotoxicity of 0.1mM cholesterol with or without CEase or
phospholipase A2 up to 100µg protein/mL was studied. The concentrations of each enzyme that
did not affect the cell viability significantly would be used to investigate whether or not these
two enzymes could facilitate cholesterol uptake into cells as stated by Mackay et al., 1997, and if
89

so, whether or not γ-oryzanol could affect the cholesterol uptake facilitated by these two
enzymes.
After reaching confluency, the cells were gently washed with HBSS twice and then
incubated with 1mL of 0.1mM cholesterol micellar solution with or without each enzyme at
various concentrations up to 100µg protein/mL for 2 hours at 37oC. After incubation, the test
solutions were pipetted out and the cells were gently washed again with HBSS twice, followed
by cell lysis for Bradford protein assay and cholesterol analysis as described in Section 4.2.7.2.
4.2.6 Effect of γ-Oryzanol on Cholesterol Uptake by Human Intestinal Cells In Vitro
4.2.6.1 Effect of γ-Oryzanol on Micellar Solubility of Cholesterol
Before the uptake experiments, cytotoxicity of cholesterol micellar solution with or
without γ-oryzanol was studied. Cells were incubated with 100µL of 0.1mM cholesterol or a
mixture containing 0.1mM cholesterol and 0.1mM γ-oryzanol for 2 hours at 37oC, followed by
cell washing and MTT assay. For the study of γ-oryzanol effect on cholesterol uptake, the
confluent cells were washed with HBSS twice and incubated with 1mL/well of micellar solutions
containing 0.1mM cholesterol with or without 0.1mM γ-oryzanol for 2 hours at 37oC, followed
by cell washing and cell lysis for Bradford protein assay and cholesterol analysis. Preincubation
of cholesterol and γ-oryzanol in vials for 1, 2 or 6 hours at 37oC before being applied to cells for
2 hours was also studied.
4.2.6.2 Effect of γ-Oryzanol on Cholesteryl Oleate Hydrolysis
First of all, cholesteryl oleate hydrolysis facilitated by various concentrations of CEase
was studied in test tubes by incubating 1mL of 0.1mM cholesteryl oleate and CEase in a serial of
concentrations from 0, 10-5 to 1µg protein/mL at 37oC for 2 hours, since the CEase concentration
should be limited and 2 hours incubation time was required for cholesterol uptake into cells. The
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lowest concentration of CEase that resulted in significant cholesterol release from hydrolysis
would be used to study the γ-oryzanol effect on CEase-facilitated cholesteryl oleate hydrolysis
and consequently the availability of cholesterol in micelles, and the cholesterol uptake by human
intestinal cells in vitro.
Secondly, cytotoxicity of 0.1mM cholesteryl oleate with or without CEase up to 10µg
protein/mL (37oC, 2 hours) was studied to determine if the micellar solutions and the enzyme
mixture would decrease cell viability. The cholesterol uptake into the cells was then studied,
where the only source of cholesterol for uptake resulted from 0.1mM cholesteryl oleate
hydrolysis (37oC, 2 hours) facilitated by various concentrations (0.001 to 10µg protein/mL) of
CEase.
Thirdly, the γ-oryzanol effect on cholesteryl oleate hydrolysis and cholesterol, the
product after hydrolysis, and uptake into cells was investigated by applying 0.1mM cholesteryl
oleate with or without 0.1mM γ-oryzanol with 0.05µg protein/mL CEase to cells for 2 hours at
37oC. The γ-oryzanol effect on micellar solubility of cholesteryl oleate and consequently its
availability for hydrolysis catalyzed by CEase was also studied by preincubating 0.1mM
cholesteryl oleate micellar solutions with or without 0.1mM γ-oryzanol in vials for 1 hour at
37oC before being applied to cells for 2 hours at 37oC. After incubation, the cells were washed
and lyzed for Bradford protein assay and cholesterol analysis.
4.2.7 Solvent Extraction and Chemical Analysis
4.2.7.1 Analysis of γ-Oryzanol Using HPLC
To determine the γ-oryzanol concentration remaining in the micellar solutions,
hexane/isopropanol (2:1:1) (×1) and hexane (×3) extraction was performed for each sample. The
organic layers were collected, combined and evaporated under vacuum. The residue that
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remained was dissolved in mobile phase and ultrasonicated to help dissolve if necessary,
followed by HPLC.
A reverse-phase HPLC system developed by Xu and Godber (1999) was used to
determine γ-oryzanol concentration. It consisted of a pump (Waters 510 HPLC Pump, Waters
Co., Milford, MA), an autosampler (Waters 715 Sample Processor), a column (C18,
25cm×4.6mm diameter, MICROSORB-MV 100 Å, Varian, Walnut Creek, CA) and a UV
detector (wavelength 330 nm, Waters 486 Tunable Absorbance Detector). The mobile phase was
methanol, acetonitrile, dichloromethane and acetic acid (50:44:3:3) with a flow rate maintained
at 1.4 mL/min. One hundred µL of each sample was injected each time. Retention times for γoryzanol was 5-9 minutes. Millenium32 software (Waters Co., Milford, MA) was used to record
chromatograms and integrate peak areas. A standard curve of γ-oryzanol (concentration versus
integrated area) was constructed to determine γ-oryzanol concentration in samples.
4.2.7.2 Cholesterol Analysis by GC/MS and Bradford Protein Assay
To determine cholesterol concentration in cell samples after treatment with test solutions,
the cells were washed with HBSS twice and cell lysis was accomplished using 400µL/well of 1N
NaOH at 37oC for 30 minutes, neutralized in 400µL/well of 1N HCl and pipetting up and down
to break cell clumps to make a homogeneous cell suspension. Bradford protein assay was
performed first to determine the amount of cell protein in the cell suspension. Two aliquots of
20µL homogenized cell suspension were diluted to 1mL with distilled deionized water and then
mixed with 1mL of Bradford protein reagent. After 5 minutes at room temperature in the dark,
the spectrum from 350 to 800nm was scanned first using a spectrophotometer to choose
wavelengths for the maximum absorbance and the background. A serial dilution of bovine serum
albumin at 0, 2, 4, 6µg/mL was used to construct a standard curve (concentration versus
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absorbance (Amax−Abackground)). The crude protein concentration in each cell sample was
calculated by converting the absorbance to concentration using the standard curve and
multiplying the proper dilution factor.
The remaining cell suspension was spiked with 25µL of 1mM β-sitosterol in isopropanol
as an internal standard and then extracted using hexane:isopropanol (3:1) (×1) and hexane (×3).
A sample of cell suspension without being spiked with β-sitosterol after cells were incubated
with 0.1mM γ-oryzanol micellar solution for 2 hours at 37oC and washed with HBSS twice was
also tested to determine whether or not β-sitosterol existed. The organic layers were collected,
combined and mixed with sodium sulfate anhydrous to remove water. The solvent was
evaporated under vacuum. To determine cholesterol concentration, each sample with dried
residue from cell suspension or micellar solution after γ-oryzanol analysis by HPLC was
derivatized

first

with

100µL

of

trimethylsilylation

reagents,

N,O-

bis(trimethylsilyl)trifluoroacetamide (BSTFA) and trimethylchlorosilane (TMCS) (99:1), and
100µL pyridine to remove any possible water that could also react with the trimethylsilylation
reagents. After incubation in a shaking water bath at 30oC for 2 hours, all samples were stored at
4oC until GC analysis, which was usually done within 24 hours.
The GC system (Varian CP-3800, Walnut Creek, CA) consisted of a glass injection port
(splitless, 300oC) and a fused silica capillary column with low polarity (SPB-5, 30m x 0.25mm
diameter and 0.1µm film thickness, Supelco Inc., Bellefonte, PA). The oven temperature was
ramped from 100oC to 280oC with heating rate of 3oC/min and helium was the carrier gas
maintained at a flow rate of 1.0mL/min. One µL of each sample was injected with split ratio 0
from 0-0.2 minutes and 10000 from 0.2-60 minutes. The GC system was coupled with an MS
detector (Varian Saturn 2200) with the following conditions: trap temperature 170oC, manifold
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temperature 65oC and transfer line temperature 170oC; axial modulation 3.9 volts; mass range,
m/z 45-650; EI auto ionization mode: scan time 0.39 seconds/scan, emission current 10µamps,
pre-scan ionization time 100 µsecond and maximum ionization time 25000 µsecond.
The quantitation ions for area integration were 330+354+369+458 m/z for cholesterol and
397+358+382+487 m/z for β-sitosterol. The standard curves of cholesterol and β-sitosterol were
constructed (concentration versus peak area). Total cholesterol concentration in each cell sample
was normalized with β-sitosterol and expressed in µmole cholesterol/mg cell protein.
Statistical analysis used proc mix in SAS version 8.2 (SAS Institute Inc., Cary, NC) (see
Appendix I for SAS codes).
4.3 Results and Discussion
4.3.1 Cholesterol Analysis by GC/MS and Internal Standard
After treatment, cells were usually lyzed in 1N NaOH or 1% sodium dodecyl sulfate
(SDS) in order to prepare them for GC/MS analysis. Since lipid extraction would be performed
later, NaOH was used instead of SDS, which could also be extracted and complicate the analysis.
In this case, cholesteryl esters if present would be hydrolyzed to the free form of cholesterol in
1N of NaOH. Therefore, the cholesterol concentration measured was the total amount of
cholesterol in cell suspension, including free and ester forms of cholesterol.
To determine the amount of cholesterol uptake into cells in vitro, cholesterol labeled with
radioisotopes such as 3H or 14C and scintillation counter to measure radioactivity have typically
been used. However, in this study GC/MS was used instead. There are several disadvantages to
using radioisotopes including the safety issue and inconvenience such as that involving lipid
extraction and other methods (i.e. thin layer chromatography) to separate the labeled compounds
in the mixture and cleaning up waste, tools and machinery after use. On the other hand, GC/MS

94

provided a means to measure both free and ester forms of cholesterol or other substances
simultaneously.
α-Cholestane has usually been used as an internal standard in cholesterol analysis, but in
this case, because it had the same retention time as cholesteryl oleate under GC/MS analysis, it
could interfere with the determination of certain ions selected for area integration in the
calculation of concentration. β-Sitosterol was then used as an internal standard in this study
because its chemical structure is similar to cholesterol. Also, β-sitosterol resulting from γoryzanol uptake into cells was not found in cell suspension determined by GC/MS and the CEase
concentration used for cholesteryl ester hydrolysis was only 0.05µg protein/mL, which did not
degrade γ-oryzanol and produce β-sitosterol (see the next chapter and Figure 5.7). Therefore, βsitosterol concentration was not overestimated and it could be used as an internal standard in cell
samples.
4.3.2 Effect of γ-Oryzanol on Micellar Solubility of Cholesterol and Cholesteryl Oleate
After 24-hour incubation of 0.1mM cholesterol or cholesteryl oleate micellar solution
spiked with 0.1mM γ-oryzanol, cholesterol, cholesteryl oleate and γ-oryzanol all lost some
degree of micellar solubility in this in vitro model. However, there were no significant
differences after incubation with or without γ-oryzanol in cholesterol (p=0.5622) or in
cholesteryl oleate (p=0.3597) recovered in the supernatant of the micellar solution (Figure 4.1(a)
and (b) and Appendix III(a)). There was a tendency towards lower %recovery of cholesteryl
oleate in the supernatant micelles than that of cholesterol, which indicated that γ-oryzanol might
be more likely to affect cholesteryl oleate than cholesterol. The reasons may be related to
differences in polarity and molecular weight. The polarity of cholesterol is higher with the free
hydroxyl group than when it is esterified with a fatty acid. When forming a micelle in the
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Figure 4.1. Effect of γ-oryzanol on micellar solubility of cholesterol and
cholesteryl oleate. (n=2×2 replications. Significant differences
(p<0.05) are expressed by different letters.)
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aqueous environment, the hydrophobic regions are in the interior while the hydrophilic regions
are at the surface. As a larger molecule that is less polar, cholesteryl oleate would occupy more
of the emulsifier’s hydrophilic regions to remain stable in the micelle. With the fixed micellar
composition, it is reasonable that the micellar solubility of cholesteryl oleate was affected more
by γ-oryzanol, which is also a large molecule with low polarity.
Similarly, from the aspect of γ-oryzanol competing with cholesterol and cholesteryl
oleate for the limited micellar space, %recovery of γ-oryzanol in the supernatant of micellar
solution was significantly lower with the presence of cholesteryl oleate than that with cholesterol
(p<0.05) (Figure 4.1(c) and Appendix III(a)). This may also explain why micellar solubility of
cholesteryl oleate was disturbed to a greater degree by γ-oryzanol.
Therefore, since hydrophobic substances such as cholesterol and cholesteryl oleate must
form micelles in order for digestion and absorption in the human intestines, γ-oryzanol may have
an effect to exclude cholesterol and cholesteryl oleate from the micelles and consequently may
decrease the availability of cholesteryl oleate for hydrolysis and cholesterol for uptake into cells.
4.3.3 Effect of γ-Oryzanol on Cholesterol Esterase-Facilitated Cholesteryl Oleate Hydrolysis
Before the study of the γ-oryzanol effect, cholesteryl oleate hydrolysis facilitated by a
serial concentration of CEase was investigated. The results showed that CEase was responsible
for the release of cholesterol from cholesteryl oleate and the degree of cholesteryl oleate
hydrolysis depended on the concentration of CEase (Figure 4.2). The higher the CEase
concentration, the more cholesterol was released from cholesteryl oleate hydrolysis. In order to
study the inhibitory effect of γ-oryzanol, the CEase concentration should be limited and much
less than the substrate. Thus, CEase at concentration of 0.1µg protein/mL was chosen because it
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was the lowest concentration that showed significantly different activity from the control (no
enzyme) (p<0.05) in the production of detectable cholesterol.
A commonly used approach to studying enzyme mechanisms is through the use of the
Michaelis-Menten equation, which was adapted in order to understand the inhibition effect of γoryzanol on CEase. One of the fundamental concepts in this approach is that the substrate
concentration affects the rate of a reaction catalyzed by an enzyme. However, it is complicated to
study substrate concentration effect since it changes over the reaction period. To simplify, the
very short time following the start of the reaction, when the substrate concentration is much
greater than the enzyme concentration, is studied instead. At the beginning, enzyme is mixed
with the excess amount of substrate and the enzyme-substrate complex (ES) builds up quickly,
which is called the pre-steady state and is usually too short to measure. Then a steady-rate state is
achieved, in which the ES reaches equilibrium where the rate of ES breakdown is equal to ES
formation. This kind of analysis is referred to as steady-state kinetics with the basic hypothesis
by Michaelis and Menten that ES breakdown to free enzyme and product is the rate-limiting step
in the reaction.
The initial reaction rate (or initial velocity), designated Vo, reflects the steady state and is
determined by the ES breakdown to give product. In this case, Vo was measured as the rate of the
product (cholesterol) concentration over the time of the early (first 5 minutes) reaction. The
relationship between Vo and the substrate (cholesteryl oleate) concentration with a constant
enzyme (CEase) concentration was constructed (Figure 4.3). It showed that if the cholesteryl
oleate concentration reach infinity, Vo reaches constant at its maximum, designated Vmax, and
when Vo equals to a half of the Vmax, the cholesteryl oleate concentration equals to MichaelisMenten constant, designated Km. The type of inhibition mechanism of γ-oryzanol could then be
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determined by comparing Km1 and Vmax1 values without γ-oryzanol to Km2 and Vmax2 values with
γ-oryzanol.
With these concepts, the study of the γ-oryzanol effect was done by incubating 0.2mM
cholesteryl oleate with 0.1µg protein/mL CEase with or without 0.2mM γ-oryzanol at 37oC for 5
minutes. Even though Vo means initial rate in a sufficiently short time at the beginning of the
reaction, incubation time less than 5 minutes was difficult to access and this approach was also
used in the study of CEase activity by Mackay et al., 1997. No internal standard was used in this
case because β-sitosterol may be produced from γ-oryzanol degradation catalyzed by CEase and
there was no proper internal standard in this case. The results expressed in Michaelis-Menten
plot (Figure 4.3) showed that the effect of cholesteryl oleate concentration on cholesterol release
was significant, which demonstrated the fundamental concept of this approach that the substrate
concentration affects the rate of the reaction catalyzed by an enzyme.
By transforming a Michaelis-Menten plot to a double-reciprocal, or Lineweaver-Burk
plot, 1/Vo (Y) versus 1/[cholesteryl oleate] (X) becomes a simple linear relationship
(Y=βo+β1X), where the intercept (βo) equals to 1/Vmax and the slope (β1) equals to Km/Vmax. The
type of inhibition mechanism of γ-oryzanol could then be more easily observed (Figure 4.4) and
compared by the changes of Km1 and Vmax1 of the straight line without γ-oryzanol to that, Km2
and Vmax2, with γ-oryzanol.
Relative to γ-oryzanol inhibition, Km1 was not significantly different from Km2 and Vmax1
was also not significantly different from Vmax2. Although not significant, the divergence in the
plots might still suggest that γ-oryzanol tended to decrease Vmax. This means that, with the
presence of γ-oryzanol, reaction rate inclined to be lower possibly because γ-oryzanol may bind
to CEase and inactivate it, thus reducing the concentration of active CEase and hence Vmax2
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Figure 4.3. Michaelis-Menten plot of 0.2mM γ-oryzanol inhibition on
0.1µg protein/mL cholesterol esterase-facilitated cholesteryl
oleate hydrolysis, 37oC, 5 minutes. (n=2×2 replications)
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would decrease. However, the substrate concentration required (Km2) to reach 1/2Vmax2 remained
the same as that (Km1) needed to reach 1/2Vmax1 without γ-oryzanol, which means that γ-oryzanol
may bind to CEase at a site distinct from that which binds cholesteryl oleate. Thus, the
inactivation occurred with or without the presence of cholesteryl oleate. This type of inhibition is
referred to as noncompetitive inhibition. Therefore, it may be suggested that γ-oryzanol might
have a tendency towards the inhibition of CEase and consequently the release of cholesterol from
the hydrolysis was lowered. The reason may be the combined effects of γ-oryzanol on CEase
inhibition and micellar solubility of cholesteryl oleate (less available for hydrolysis).
The mechanism of enzyme inhibition can be complicated, especially with measuring the
initial velocity at the very beginning of the reaction. Also, it requires that the substrate
concentration should be much higher than the enzyme concentration but it is unclear how high is
acceptable. In addition, determination of the product concentration depends on the detection limit
of the analytical method employed, which means the concentration of the product may be too
low to be detected at the initial stage of the reaction. The greatest degree of CEase inhibition by
γ-oryzanol may simply not be measured at the most appropriate moment. The use of an
appropriate internal standard is also important if GC/MS is employed. More research is needed
to further understand the characteristics of CEase, such as the hydrolytic steps from binding
cholesteryl oleate to releasing cholesterol and the reaction rates, the active site of CEase
responsible for cholesteryl ester hydrolysis and the γ-oryzanol binding site. Also, it must be
determined if regulation of CEase by other substances is present and if the CEase inactivation
will affect the digestion and metabolism of other compounds.
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4.3.4 Cholesterol Uptake by Human Intestinal Cells In Vitro
In this study, the cell line used was C2BBe1, a brush border expressing human colon cell
line cloned from the Caco-2 cell line (ATCC HTB-37), which is derived from a human colon
adenocarcinoma which has been used as a model in many studies of cholesterol uptake into the
intestinal mucosa. Besides C2BBe1, another cell line Fhs74Int (ATCC CCL-241), a human
normal small intestine cell line, was also cultured with the intention to study cholesterol uptake
in vitro. However, the cells required a relatively long time (2 weeks) to reach confluency and had
limited passages before the onset of senescence. Therefore, the C2BBe1 cell line was developed
to be a model for in vitro cholesterol uptake studies.
4.3.4.1 Effect of Cholesterol Esterase and Phospholipase A2
The results of cytotoxicity studies (Figure 4.5) showed that 0.1mM cholesterol with or
without CEase or phospholipase A2 up to 100µg protein/mL at 37oC for 2 hours did not decrease
cell viability in terms of cellular mitochondrial activity, compared to the control, serum-free and
transferrin-free culture medium. For the effect of CEase and phospholipase A2 on cholesterol
uptake, the results (Figure 4.6) showed that neither enzyme up to 100µg protein/mL significantly
increased cholesterol uptake into cells. Therefore, the study of the γ-oryzanol effect on
cholesterol uptake could not address the possibility that γ-oryzanol could inhibit CEase and
phospholipase A2 activity. Rather the focus of this experiment became the effect of γ-oryzanol on
the micellar solubility of cholesterol.
Initially, the study of the γ-oryzanol effect on CEase and phospholipase A2 was motivated
by the results from Mackay et al., 1997, who suggested that CEase and phospholipase A2 could
promote cholesterol uptake by hydrolyzing phosphatidylcholine, one of the components used to
prepare cholesterol in micelles, and therefore altering the physicochemical state of cholesterol in
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Figure 4.5. Cytotoxicity study of cholesterol incubated with γ-oryzanol,
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the intestines. However, the same results were not observed in this compared with other studies
(Shamir et al., 1995, and Huang and Hui, 1990). One of the possible reasons is that all studies
used different micellar compositions. The micelles used in this study to prepare cholesterol,
cholesteryl oleate and γ-oryzanol in aqueous solution consisted of relatively high concentrations
of oleic acid (0.5mM), 1-monoolein (0.25mM) and phosphatidylcholine (0.3mM), since
preparing γ-oryzanol micellar solution has been a challenge. Hence, micellar composition is
critical in the investigation of micellar solubility of cholesterol or γ-oryzanol.
Moreover, while the molecule weight was not provided by the manufacturer, the
concentrations of CEase and phospholipase A2 could not be expressed in terms of molarity and
be compared to the concentrations used in other studies. The concentrations of CEase and
phospholipase A2 in this study may not be sufficiently high enough to promote cholesterol
uptake. In summary, the lipid composition of micelles in human intestines is very complicated
and therefore, more research is needed to further understand the roles of CEase and
phospholipase A2 in promoting cholesterol uptake.
4.3.4.2 Effect of γ-Oryzanol on Availability of Cholesterol for Uptake
First of all, the results of cytotoxicity studies showed that 0.1mM cholesterol with or
without 0.1mM γ-oryzanol did not decrease cellular mitochondrial activity compared to the
control, serum-free and transferrin-free culture medium (Figure 4.5). As for the cholesterol
uptake, the concentration of cholesterol recovered from the cell suspension was significantly
higher in cells incubated with cholesterol than that in the control emulsion without cholesterol
(p<0.05) (Figure 4.7 and Appendix III(b)). Since cholesterol is one of the natural constituents in
the cell membrane of animal cells, even the control sample should test positive for cholesterol
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and the extra cholesterol must have resulted from the cholesterol uptake into cells or association
with cells.
The results also showed that, with or without the presence of γ-oryzanol, the cholesterol
concentrations recovered were not significantly different (p=0.6808). When cholesterol and γoryzanol were preincubated in vials for up to 6 hours before being applied to cells, the
concentrations of cholesterol recovered from cell suspensions tended to decrease more obviously
in a time-dependent manner. The longer the preincubation, the less cholesterol recovered.
Preincubation time for two hours did not show a significant difference (p=0.2105) but it showed
a significant decrease after six-hour preincubation (p<0.05) to a level equivalent to the control.
The preincubation of cholesterol alone for 6 hours caused less cholesterol uptake than without
preincubation but not significantly. Therefore, preincubation with γ-oryzanol for 6 hours had a
significant effect on decreasing cholesterol uptake and it may be due to the decreased cholesterol
micellar solubility in preincubation.
4.3.4.3 Effect of γ-Oryzanol on Cholesteryl Oleate Hydrolysis
The results of the relationship between various concentrations of CEase and the
cholesterol released from hydrolysis is shown in Figure 4.8. The relationship was concentrationdependent, which means that the more CEase catalyzed the hydrolysis, the more cholesterol was
produced. The concentration range studied was only up to 1µg protein/mL, which resulted in
only about 5% cholesterol production. It was postulated that, when applied to cells, the reaction
direction would go in favor of releasing products, which would be taken up into cells, and the
hydrolysis may not reach equilibrium. Therefore, CEase at concentration as low as 0.05µg
protein/mL was significantly different from the control (no enzyme) (p<0.05) and was sufficient
to be used later to study γ-oryzanol effect on cholesteryl oleate hydrolysis.
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As for the cytotoxicity studies, the results showed that 0.1mM cholesteryl oleate with or
without CEase up to 10µg protein/mL did not decrease cellular mitochondrial activity compared
to the control, serum-free and transferrin-free culture medium (Figure 4.9). For the uptake
studies, the results showed that, after cholesteryl oleate was incubated with cells, there was no
significant cholesterol uptake compared to the control emulsion (Figure 4.10 and Appendix
III(c)). The results also agreed with Mackay et al., 1997, that the ester form of cholesterol could
not be absorbed without prior hydrolysis. The dietary cholesteryl esters are usually hydrolyzed
by pancreatic CEase to free cholesterol in intestines before uptake. It also showed that when
cholesteryl oleate was incubated with 0.05µg protein/mL CEase, there was significantly higher
cholesterol concentration detected in the cell suspension (p<0.05). Thus, the results suggested
that cholesteryl esters could not be absorbed by intestinal cells, and in order for uptake,
hydrolysis catalyzed by CEase was necessary. The study of γ-oryzanol effect would then focus
on inhibition on CEase hydrolytic activity and micellar solubility of cholesteryl oleate
(availability for hydrolysis).
First of all, the cytotoxicity results showed that γ-oryzanol incubated with cholesteryl
oleate and CEase did not decrease the mitochondrial activity of cells (Figure 4.9). Secondly, with
the presence of γ-oryzanol, the uptake of cholesterol resulted in a trend towards decreased
cholesteryl oleate hydrolysis (p=0.1392) (Figure 4.10 and Appendix III(c)). The reason may be
due to the combined effects of γ-oryzanol on micellar solubility of cholesteryl oleate and
cholesterol, and on CEase inhibition. It may be suggested that when γ-oryzanol and cholesteryl
oleate are simultaneously present in the intestines, γ-oryzanol can affect the cholesteryl oleate
hydrolysis and then decrease the cholesterol uptake into cells.
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Furthermore, after preincubation with γ-oryzanol in vials at 37oC for 1 hour, cholesteryl
oleate hydrolysis by 0.05µg protein/mL CEase resulted in a trend towards lower cholesterol
uptake (p=0.1546) (Figure 4.10 and Appendix III(c)). This may be because γ-oryzanol disturbed
the micellar solubility of cholesteryl oleate or decreased the availability of cholesteryl oleate for
hydrolysis and cholesterol production, and therefore decreased cholesterol uptake. Thus, it may
be suggested that if γ-oryzanol is present with cholesteryl oleate for more than one hour before
interacting with CEase in the intestines, the availability of cholesteryl esters may decrease further
due to competition with γ-oryzanol and by being excluded from micelles. After interacting with
CEase, hydrolysis of cholesteryl esters might be inhibited by γ-oryzanol resulting in less free
form of cholesterol available for uptake and also the micellar solubility of the hydrolysis product,
cholesterol, may decrease, thus the cholesterol uptake into cells may consequently decrease.
Additionally, differences occurred in the preincubation times required for γ-oryzanol to
reduce cholesterol uptake between free cholesterol and cholesteryl ester. Preincubation of γoryzanol with cholesteryl oleate for 1 hour before being introduced to cells showed an effect on
cholesterol uptake relatively greater than preincubation with free cholesterol. The reason may be
due to their chemical structures and the stability of micelles as stated in Section 4.3.2. Free
cholesterol is more hydrophilic than its ester form and, reasonably, to decrease its micellar
solubility may take a longer time than with the esters. Therefore, it suggested that, in the
gastrointestinal tract before uptake, γ-oryzanol might play a bigger role in affecting micellar
solubility of cholesteryl esters than in affecting the free form of cholesterol.
Finally, when enzymes are involved, the mechanism of inhibition can be complicated.
For example, the hydrolysis and uptake of cholesterol, which was the product from the
hydrolysis, most likely occur simultaneously. Consequently, the reaction would not reach
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equilibrium because the product concentration would not increase over time (due to uptake into
cells) and the reaction direction would go toward the product. Even a small amount of CEase
may be able to facilitate hydrolysis over time as was the case with the CEase at the higher
concentration in this study. Hence, the γ-oryzanol effect on CEase inhibition might be difficult to
detect. Thus, the focus of this study became the γ-oryzanol effect on micellar solubility of
cholesteryl oleate, or availability of cholesteryl oleate for hydrolysis.
4.4 Conclusion
Many researchers have studied and found that γ-oryzanol possesses hypocholesterolemic
capacity. However, this is the first time that the possible mechanism of this γ-oryzanol function
has been approached. In addition, a cell model using human intestinal cells accompanied with
GC/MS was developed and found capable of detecting cholesterol uptake into cells in vitro.
The mechanism of the hypocholesterolemic capacity of γ-oryzanol is complicated. Since
the results of digestibility and absorbability of γ-oryzanol suggested that γ-oryzanol is poorly
absorbed by intestinal cells (see next chapter), therefore, γ-oryzanol may affect cholesterol
uptake as it takes place in the lumen of the gastrointestinal tract. This study tried to distinguish
the avenues that γ-oryzanol may influence and then develop a model to investigate the γ-oryzanol
effect from each aspect.
From the results, the hypocholesterolemic capacity of γ-oryzanol could be envisioned
from three standpoints. 1) Because the uptake of cholesteryl oleate was not found but the
hydrolysis catalyzed by CEase that generated free cholesterol was, γ-oryzanol may affect the
availability of cholesteryl esters for CEase-facilitated hydrolysis by reducing the micellar
solubility of cholesteryl esters. 2) Since dietary cholesteryl esters are usually hydrolyzed by
pancreatic CEase in the small intestines, and CEase was not found to promote free cholesterol
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uptake, the effect of γ-oryzanol focused on the inhibition of hydrolytic function of CEase, which
was to inhibit the hydrolysis of cholesteryl esters and reduce free cholesterol production. 3)
Because it was not found that the uptake of free cholesterol was promoted by CEase and
phospholipase A2, γ-oryzanol may affect the availability of free cholesterol for uptake by
decreasing its micellar solubility. Therefore, consequently, the cholesterol uptake into cells
decreased.
Some researchers also studied the binding of bile salts (i.e. Nagaoka et al., 1999, and
Ikeda et al., 1992) as a mechanism for serum cholesterol reduction. Bile salts are excreted by the
liver and stored in and released from gallbladder to duodenum in response to digestion. They are
amphipathic with both hydrophilic and hydrophobic regions and function as emulsifiers to
prevent gallstone formation resulting from the precipitation of cholesterol in bile and to form
micelles containing dietary lipids. Hence, it is reasonable that researchers should also consider
the study of the effects of γ-oryzanol on binding bile salts since the reduction of bile salt
availability for micelle formation in the small intestines would result in a decrease of micellar
solubility of cholesterol along with other lipids.
In order to do so, what must be kept in mind, however, is the analytical method to
measure bile salts, i.e. enzymatic assay using hydroxysteroid dehydrogenase should have
specificity to bile salts only and not react with γ-oryzanol to give false positives. This is because,
unlike the soy protein peptic hydrolysate in the study by Nagaoka et al., 1999, and tea catechins
in Ikeda et al., 1992, oryzanol and bile salts have similar ring structures.
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CHAPTER 5. IN VITRO DIGESTIBILITY AND ABSORBABILITY OF γ-ORYZANOL
5.1 Introduction
The absorption and metabolism of γ-oryzanol in human or animal bodies has not been
fully delineated. There are only a few of studies in English exploring this phenomenon. Many of
the studies done in the area have used animal models such as rabbits and rats (Fujiwara et al.,
1983). Measurement of γ-oryzanol and its metabolites in those studies employed thin layer
chromatography, which was the only method available prior to the development of modern
chromatographic approaches to analysis.
Therefore, with the assistance of liquid chromatography, gas chromatography coupled
with mass spectrometry and cell culture techniques, the objective of this study was to investigate
the metabolic fate of γ-oryzanol in the gastrointestinal tract by an in vitro model involving
simulated peptic and pancreatic digestion and by cell culture using human intestinal cells. The
effect of three specific pancreatic enzymes, cholesterol esterase (CEase), lipase and
phospholipase A2, on γ-oryzanol degradation and the identification of the degradation products
were studied.
5.2 Materials and Methods
5.2.1 Materials and Reagents
γ-Oryzanol was obtained from crude rice bran oil using preparative normal-phase high
performance liquid chromatography (HPLC) and crude rice bran oil was extracted from milled
rice bran according to the method developed by Xu and Godber (1999). The preparative HPLC
system consisted of a Waters (Milford, MA) Prepak® RCM base connected with two cartridges
(each was a 25mm×10cm Prep Nova-Pak HR silica with particle size 6µm) and a Guard-Pak
insert, a U6K manual injector, a 510 pump and a Lambda-Max 481 LC Spectrophotometer
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(wavelength 330 nm). Mobile phase was methanol with a constant flow rate at 15 mL/min and
2mL of the crude oil were injected each time. The eluate containing γ-oryzanol was collected
(25-30min) and the solvent was evaporated.
Oleic acid, 1-monoolein, lecithin, sodium taurocholate, ferulic acid, stigmasterol,
Na2HPO3, MTT assay kit, Bradford reagent, Hank’s balanced salts, porcine bile extract, porcine
pepsin, porcine pancreatin, containing many enzymes including amylase, trypsin, lipase,
ribonuclease and protease, porcine pancreatic cholesterol esterase, lipase, phospholipase A2 and
trimethylsilylation reagents (N,O-bis(trimethylsilyl)trifluoroacetamide and trimethylchlorosilane
(99:1)) were purchased from Sigma, St. Louis, MO. HCl and NaHCO3 were purchased from
Mallinckrodt, Inc., Paris, KY. NaOH, NaCl, KH2PO3, hexane and isopropanol were purchased
from Fisher Scientific, Fair Lawn, NJ. Tris(hydroxymethyl)aminomethane was purchased from
Amresco, Solon, OH. Culture plates were purchased from Corning Inc., Corning, NY, and the
sterile disposable syringe filter was 0.2µm PES purchased from Whatman, Clifton, NJ.
Phosphate buffered saline (PBS) was prepared by dissolving 0.9g of NaCl, 0.111g of
Na2HPO3 and 0.03g of KH2PO3 in about 90mL of distilled deionized water, adjusting pH to 7
with 10N NaOH and diluting to 100mL volume with water. Tris-HCl buffer (0.1M) was prepared
by dissolving 1.2114g of Tris(hydroxymethyl)aminomethane in about 90mL of distilled
deionized water, adjusting pH to 7.5 with 10N of HCl and diluting to 100mL volume with water.
5.2.2 Preparation of γ-Oryzanol Micellar Solution
γ-Oryzanol micellar solution was prepared by first dissolving 0.1mM γ-oryzanol mixed
with

0.5mM

oleic

acid,

0.25mM

1-monoolein

and

0.3mM

lecithin

in

solvent

(hexane:isopropanol=3:1). After the solvent was dried under a vacuum evaporator with
temperature set at 45oC (CentriVap Console, Labconco Inc., Kansas City, MO), 6.6mM sodium
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taurocholate in buffer or culture medium free of serum and transferrin was added to the dried
lipids and then ultrasonicated (Sonic Dismembrator 60, Fisher Scientific, Fair Lawn, NJ) in an
ice bath for 45 minutes. The micellar solution was free of precipitate.
5.2.3 Preliminary Study of In Vitro Digestibility of γ-Oryzanol
Digestibility of γ-oryzanol was determined by a modified in vitro model (Ames et al.,
1999) to simulate digestion in the human stomach and small intestines. Crystalline γ-oryzanol,
1mg, or 500µL of 0.2mM γ-oryzanol micellar solution in PBS (1mM oleic acid, 0.5mM 1monoolein and 0.6mM lecithin, without sodium taurocholate) was mixed with 3mL of distilled
water and 2mL of freshly made pepsin solution (0.32g/mL in 0.1N HCl) and pH was adjusted to
2 using 6N HCl. After peptic digestion in a shaking water bath at 37oC for 2 hours, 1mL of a
freshly prepared bile (25mg/mL) and pancreatin (4mg/mL) mixture in 0.1N NaHCO3 was added
to the digest with pH adjusted to 7 using 0.5N NaHCO3 and incubated at 37oC for 2 hours.
Digestibility of ferulic acid and stigmasterol (1.0mg crystalline each) were also tested.
5.2.4 Digestibility of γ-Oryzanol In Vitro by Pancreatic Enzymes, Cholesteryl Esterase, Lipase
and Phospholipase A2
To investigate the effect of specific pancreatic enzymes on digestibility of γ-oryzanol,
CEase, lipase and phospholipase A2 were studied. Each enzyme at a serial concentrations of 0.1,
1, 10, 100 or 500µg protein/mL was applied to 1mL of 0.1mM γ-oryzanol micellar solution
containing 0.5mM oleic acid, 0.25mM 1-monoolein, 0.3mM lecithin and 6.6mM sodium
taurocholate in 0.1mM Tris-HCl buffer (pH 7.5) for 1.5 hour at 37oC, followed by solvent
extraction, determination of the remaining γ-oryzanol concentrations by HPLC analysis and
identification of digestion products by a gas chromatography (GC) coupled with mass
spectrometry (MS) analysis.
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5.2.5 Study of γ-Oryzanol Uptake by Human Intestinal Cells In Vitro
5.2.5.1 Cell Culture
γ-Oryzanol uptake by human intestines in vitro was investigated by using C2BBe1 cells
(ATCC CRL-2102). To maintain the cell line, the cells were subcultured every 4 days when
confluent. The old medium was pipetted out and discarded and the cells were washed with
0.25% trypsin solution three times. At the third time the trypsin solution remained until the cells
detached from the flask (about 10 minutes at 37oC). The cell suspension was pipetted up and
down to break any clumps and subcultured (split ratio 1:3) with new medium (90% DMEM with
4mM L-glutamine, 1.5g/L sodium bicarbonate and 4.5g/L glucose and supplemented with
0.01mg/mL human transferrin; 10% fetal bovine serum). For γ-oryzanol uptake experiments, the
cell suspension was diluted in new medium to 2x105 cells/mL and 1mL was transferred to each
well (area=2cm2) of the 24-well culture plates, which resulted in 105cells/cm2. For cytotoxicity
studies, 96-well plates were used and 100µL of the cell suspension was cultured in each well.
Cell count was performed at each subculture to ensure consistency for each experiment.
5.2.5.2 Cytotoxicity Study of γ-Oryzanol Micellar Solution Using an MTT Assay
To study cytotoxicity of γ-oryzanol micellar solution, a 3-(4,5-dimethylthiazol-yl)-2-5diphenyltetrazolium bromide (MTT) assay kit was used to measure cell viability in terms of the
activity of mitochondrial dehydrogenases in living cells. After subculture in 96-well culture
plates and reaching confluency, the cells were washed gently twice with Hank’s balanced salt
solution (HBSS) and applied at 100µL/well of γ-oryzanol micellar solution prepared in culture
medium free of serum and transferrin for 2 hours at 37oC. After incubation, the γ-oryzanol
solution was removed and the cells were gently washed twice with HBSS, followed by
40µL/well of 1.25mg/mL MTT in HBSS, which has a yellow color. After incubation at 37oC in
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the dark for 2 hours, the mitochondrial dehydrogenases of viable cells cleaved the tetrazolium
ring and yielded purple formazan crystals, which are insoluble in aqueous solution. Then
100µL/well of MTT solubilization solution containing 10% Triton X-100 plus 0.1N HCl in
anhydrous isopropanol was added to solubilize purple formazan crystals. Pipetting up and down
at least 100 times helped solubilization in dense culture situation. Absorbances at 570nm for
color development and at 690nm for background were read using a microplate
spectrophotometer (SPECTRAmax® PLUS, Molecular Devices Co., Sunnyvale, CA). An
increase or decrease of cell numbers after exposure to a test solution would correspond to a
concomitant change in the amount of purple formazan formed or in the optical density at
absorbance 570nm. The cell viability under exposure to a test compound was expressed in
%cellular mitochondrial activity, which was the ratio of absorbance reading difference between
570nm and 690nm of test compound (A570 − A690) to that of the control (Ao570 – Ao690):
A570 − A690
%Cellular mitochondrial activity =  × 100%
Ao570 – Ao690
5.2.5.3 Study of γ-Oryzanol Uptake by Cells In Vitro
C2BBe1 cells were incubated with 1mL/well of the γ-oryzanol micellar solution in
serum-free and transferrin-free culture medium for 2 hours at 37oC. After incubation, the test
solution was pipetted out and the cells were washed gently with HBSS twice. The cells were
lyzed in 400µL/well of 1N NaOH at 37oC for 30 minutes and neutralized by 400µL/well of 1N
HCl before further γ-oryzanol determination.
5.2.6 Analysis of γ-Oryzanol and Ferulic Acid Using Solvent Extraction and HPLC
To determine the remaining γ-oryzanol and ferulic acid concentrations and the
hydrophobic digestion products after digestion, hexane/ethyl acetate/isopropanol (2:1:1) (×1) and
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hexane (×3) extraction was performed for each sample. The organic layers were collected,
combined and mixed with sodium sulfate anhydrous to remove water. The solvent was
evaporated under vacuum. The residue remaining was dissolved in mobile phase and
ultrasonicated to help dissolve if necessary, followed by liquid chromatography to determine
concentrations of γ-oryzanol and ferulic acid.
A reverse-phase HPLC system developed by Xu and Godber (1999) was used to
determine γ-oryzanol and ferulic acid concentrations. It consisted of a pump (Waters 510 HPLC
Pump, Waters Co., Milford, MA), an autosampler (Waters 715 Sample Processor), a column
(C18, 25cm×4.6mm diameter, MICROSORB-MV 100 Å, Varian, Walnut Creek, CA) and a UV
detector (wavelength 330 nm, Waters 486 Tunable Absorbance Detector). The mobile phase was
methanol, acetonitrile, dichloromethane and acetic acid (50:44:3:3) with a flow rate maintained
at 1.4 mL/min. One hundred µL of each sample was injected each time. Retention times for γoryzanol and ferulic acid were 5-9 minutes and 1.5 minutes, respectively. Millenium32 software
(Waters Co., Milford, MA) was used to record the chromatograms and integrate peak areas. A
standard curve of γ-oryzanol (concentration versus integrated area) was constructed to infer γoryzanol concentration in samples.
5.2.7 Identification of γ-Oryzanol Digest Products by GC/MS
After HPLC analysis, the solvent in each remaining sample was evaporated for further
gas chromatography and mass spectrometry (GC/MS) analysis. Before being injected into
GC/MS, each sample with dried residue was derivatized using 100µL of trimethylsilylation
reagents,

which

were

N,O-bis(trimethylsilyl)trifluoroacetamide

(BSTFA)

and

trimethylchlorosilane (TMCS) (99:1), and 100µL pyridine to remove any possible water, which
could also react with the trimethylsilylation reagents. After incubation in a shaking water bath at
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30oC for 2 hours, all samples were stored at 4oC until GC analysis, which was usually done
within 24 hours.
The GC system (Varian CP-3800, Walnut Creek, CA) consisted of a glass injection port
(splitless, 300oC) and a fused silica capillary column with low polarity (SPB-5, 30m x 0.25mm
diameter and 0.1µm film thickness, Supelco Inc., Bellefonte, PA). The oven temperature was
ramped from 100oC to 280oC with heating rate of 3oC/min and helium was the carrier gas
maintained at a flow rate of 1.0mL/min. One µL of each sample was injected with split ratio 0
from 0-0.2 minutes and 10000 from 0.2-60 minutes. The GC system was coupled with an MS
detector (Varian Saturn 2200) with the following conditions: trap temperature 170oC, manifold
temperature 65oC and transfer line temperature 170oC; axial modulation 3.9 volts; mass range,
m/z 45-650; EI auto ionization mode: scan time 0.39 seconds/scan, emission current 10µamps,
pre-scan ionization time 100 µsecond and maximum ionization time 25000 µsecond.
5.3 Results and Discussion
5.3.1 Digestibility of γ-Oryzanol In Vitro by Pepsin and Bile-Pancreatin
The actual digestive process in humans is more complicated than that depicted in this in
vitro experiment. The capacity of the stomach is 50mL when empty and can expand to 1 to 1.5
liters when filled (Wardlaw and Insel, 1993). The small intestine, composed of the duodenum,
the jejunum and the ileum, is altogether approximately 10 feet long. Food stays for 2 to 3 hours
in the stomach and 3 to 10 hours in the small intestines. Since γ-oryzanol was the only compound
of interest tested in the absence of the complexity of other foods, which require longer time to
digest, the scale of the model to study digestibility of γ-oryzanol was reduced but maintained in
approximately the same ratio with pepsin, bile and pancreatin solutions as the model used by
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Ames et al. (1999). For the same reason, the incubation time was also reduced to 2 hours with
pepsin and then 2 hours with pancreatin.
The results showed that γ-oryzanol concentrations in both forms of crystalline and
micellar solution decreased after peptic and pancreatic digestion compared to incubation with
water (Figure 5.1). Interestingly, the susceptibility of these two forms of γ-oryzanol to digestion
was not equal. After either peptic or pancreatic digestion, γ-oryzanol recovered from micellar
solution was less than that recovered from the crystalline form. It may be explained that the γoryzanol in crystalline form, which was insoluble in aqueous solution, was not evenly distributed
in the solution to react with pepsin and pancreatin while the micellar form was. Additionally,
even though little chemical digestion occurs in the stomach except protein hydrolysis, %recovery
of γ-oryzanol decreased more significantly in the form of micelles when incubated with HCl and
without pepsin, which may indicate that the effects of both low pH and pepsin on structural
integrity of γ-oryzanol exists. The further contribution of pancreatin to γ-oryzanol degradation
was also present in both forms of γ-oryzanol, crystalline and micelles, when compared to the γoryzanol recoveries after incubation with NaHCO2 and without pancreatin.
In regard to the pathway of γ-oryzanol degradation during digestion, one could
hypothesize that γ-oryzanol might be hydrolyzed by pepsin and the pancreatic enzymes at the
ester bond since the chemical structure of γ-oryzanol consists of a terpene alcohol or sterol
esterified with a ferulic acid (Figure 2.2(b)). On the HPLC chromatograms of γ-oryzanol after
peptic and pancreatin digestion (Figure 5.2), all the γ-oryzanol components decreased and ferulic
acid, which if present would also absorb at 330nm with the retention time at 1.5 minutes (Figure
3.1(b)), was not found after either peptic or pancreatic digestion. Also, the further analysis of
digestion products by GC/MS showed that the amount of terpene alcohol or sterol portion of γ124
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Figure 5.1. In vitro digestibility of γ-oryzanol in forms of crystalline or micellar solution incubated with
water for 4 hours or HCl or pepsin for 2 hours and then NaHCO3 or bile and pancreatin mixture
for 2 hours at 37oC. (n=2×2 replications. Significant differences (p<0.05) are expressed by
different letters.)
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Figure 5.2(b). HPLC chromatogram of 0.1mM γ-oryzanol after peptic (37oC, 2 hours) and
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oryzanol did not increase (Figure 5.3). However, this was inconclusive as to whether or not the
breakdown of the ester bond occurred. The digestibility of stigmasterol and ferulic acid was also
studied and the results showed that the concentrations of both decreased after digestions (Figure
5.4 and 5.5). Thus, if the ester bond of γ-oryzanol is hydrolyzed, the sterols or terpene alcohols
and ferulic acid produced might be further degraded. Otherwise, degradation of γ-oryzanol might
undergo a different pathway.
Absorption and metabolism of γ-oryzanol in rats has been studied by Fujiwara et al.,
1983. In the first 72 hours after oral administration of 14C-labeled at the C-3 position of ferulic
acid, radioactivity analysis showed that 9.8% of the dose (50mg/kg) was excreted in the urine,
which was not intact γ-oryzanol. But their results from the experiment of in situ intestinal
absorption showed that, while 89.4% of the radioactivity remained in the luminal fluid mostly as
intact γ-oryzanol suggesting γ-oryzanol was poorly absorbed, more than 80% of the absorbed
radioactivity (=0.16% of the dose) was intact γ-oryzanol, transferred into the mesenteric vein and
then into portal vein, and 10 to 20% of the absorbed dose was metabolized in the intestinal
tissues to yield ferulic acid. However, this in situ experiment did not cause the γ-oryzanol to
undergo digestions in stomach, duodenum and jejunum, where secreted digestive enzymes could
cause γ-oryzanol degradation to occur.
The metabolic fate of ferulic acid has also been studied by Booth et al. (1957). In both
studies, the proposed urinary metabolites of ferulic acid were dihydroferulic acid, vanillic acid,
m-coumaric acid, m-hydroxyphenylpropionic acid, hippuric acid and m-hydroxyhippuric acid
(see chemical structures in Figure 2.6). None of these metabolites were found in the digestion
products in this study, based on the GC chromatograms and identification by the MS spectrum of
the peptic and pancreatic digest products of ferulic acid and γ-oryzanol, assuming that
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Stigmasterol-TMS

Figure 5.4. GC chromatograms of stigmasterol before and after peptic and pancreatic digestion

Retention time (minute)

(b) stigmasterol after peptic and pancreatic digestion

(a) stigmasterol without digestion
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ferulic acid-TMS

Figure 5.5. GC chromatograms of ferulic acid before and after peptic and pancreatic digestion

Retention time (minute)

(b) ferulic acid after peptic and pancreatic digestion

(a) ferulic acid without digestion

hexane/ethyl acetate/isopropanol (2:1:1) plus hexane (×3) should be efficient to extract ferulic
acid and those metabolites if present. However, during that period when the previous studies
were done, thin layer chromatography was mostly employed and using Rf values to identify γoryzanol and its metabolites may be questionable. More research is required to further delineate
the digestibility and metabolism of γ-oryzanol.
Therefore, all the results may imply that γ-oryzanol undergoes a more complicated
degradation through the gastrointestinal tract rather than the simple breakdown of the ester bond
between terpene alcohol or the sterol portion of γ-oryzanol and ferulic acid.
This experiment focused mainly on chemical digestibility of γ-oryzanol with pepsin and
pancreatin and the digestion products yielded from hexane/ethyl acetate/isopropanol (2:1:1)
extraction and, therefore, is of a preliminary nature. The effects of gastric and intestinal muscle
contraction, the movement of the foods in the gastrointestinal tract, the regulation of the enzyme
secretions, the interrelationships with liver and pancreas and the interrelationship between
digestive and absorptive processes on digestibility of γ-oryzanol were beyond the scope of this
study.
5.3.2 Digestibility of γ-Oryzanol by Pancreatic Enzymes, Cholesterol Esterase, Lipase and
Phospholipase A2
Since it was found that γ-oryzanol concentration decreased after peptic and pancreatic
digestion, it was further studied to determine if three of the pancreatic enzymes, CEase, lipase
and phospholipase A2, were responsible for γ-oryzanol degradation. The results showed that
%recovery of γ-oryzanol after incubation with a concentration of CEase higher than 10µg
protein/mL significantly decreased in a CEase concentration-dependent manner (p<0.05) (Figure
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5.6). On the other hand, the %recovery after incubation with lipase or phospholipase A2 was not
in a concentration-dependent manner and the differences were not as pronounced as with CEase.
Furthermore, on the HPLC chromatograms of γ-oryzanol after digestion by pancreatic
enzymes (Figure 5.7), campesteryl ferulate and sitosteryl ferulate decreased more obviously,
which may imply that they were more susceptible to pancreatic enzyme digestion. The digestion
products of γ-oryzanol incubated with CEase were further analyzed by GC/MS and it was found
that the amount of campesterol and sitosterol increased (Figure 5.8), which may be because
campesteryl ferulate or sitosteryl ferulate was hydrolyzed by CEase at the ester bond to produce
campesterol or sitosterol and ferulic acid. However, ferulic acid was not found on any of the
HPLC and GC chromatograms.
The reason that campesteryl ferulate and sitosteryl ferulate were more susceptible than
the other components of γ-oryzanol to CEase may be due to the similarity of their chemical
structures with cholesterol’s. Their ring structures are identical with cholesterol (Figure 2.2), as
they have neither the dimethyl groups at C-4 position nor the methyl group at C-14 position,
while some of the other γ-oryzanol components do. The side chain structures have only an extra
methyl group difference at C-24 position for campesteryl ferulate and an extra ethyl group for
sitosteryl ferulate. This could also explain that the amount of campesteryl ferulate decreased
more after peptic and pancreatic digestion.
Similarly, none of the urinary ferulic acid metabolites, dihydroferulic acid, vanillic acid,
m-coumaric acid, m-hydroxyphenylpropionic acid, hippuric acid and m-hydroxyhippuric acid,
summarized by Fujiwara et al., 1983, and Booth et al., 1957, were found in this study, according
to the GC chromatograms and the identification on the MS spectrum of the CEase, lipase and
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Figure 5.6. Digestibility of γ-oryzanol in vitro by cholesterol esterase
(CEase), lipase or phospholipase A2 after incubation for
1.5 hours at 37oC. (n=2×3 replications)
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0 .0 0

2 0 .0 0

4 0 .0 0

6 0 .0 0

8 0 .0 0

1 0 0 .0 0

1 2 0 .0 0

136

mV

1 .0 0

2 .0 0

3 .0 0

4 .0 0
5 .0 0
M inute
s (minute)
Retention
time

6 .0 0

7 .0 0

8 .0 0

Figure 5.7(b). HPLC chromatogram of 0.1mM γ-oryzanol incubated with 500µg protein/mL of cholesterol
esterase at 37oC for 1.5 hours
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Figure 5.7(c). HPLC chromatogram of 0.1mM γ-oryzanol incubated with 500µg protein/mL of lipase
at 37oC for 1.5 hours
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Figure 5.7(d). HPLC chromatogram of 0.1mM γ-oryzanol incubated with 500µg protein/mL of
phospholipase A2 at 37oC for 1.5 hours
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phospholipase A2 digestion products of γ-oryzanol. This might suggest that ferulic acid was
further degraded in a different pathway.
Sterol specificity of CEase has been studied by Swell et al. (1954) who summarized that
cholesterol, sitosterol and stigmasterol esters with butyric acid were hydrolyzed very rapidly
while the hydrolysis of their esters with oleic acid was not as rapid. The order of hydrolytic
activity in the first 4 hours was cholesteryl oleate>sitosteryl oleate>stigmasteryl oleate. The
results from our study may also provide some additional information about the specificity of
CEase, which indicated that the specificity of pancreatic CEase was found not only for
cholesterol esters, in this case cholesteryl oleate, but also for campesteryl ferulate and sitosteryl
ferulate.
5.3.3 Study of γ-Oryzanol Uptake by Human Intestinal Cells In Vitro
First of all, the cytotoxicity results showed that 0.1mM γ-oryzanol in micellar solution
did not decrease cellular mitochondrial activity after 2-hour incubation at 37oC, compared to the
control, serum-free and transferrin-free culture medium (Figure 5.9). Secondly, since NaOH was
used as the cell lysis solution, the effect on γ-oryzanol hydrolysis was also studied by incubation
of γ-oryzanol with 1N NaOH without cells at 37oC for 30 minutes. It was found that %recovery
of γ-oryzanol was 97.7% and, therefore, cell lysis solution would not cause the degradation of
the recovered γ-oryzanol if γ-oryzanol was absorbed. Thirdly, the uptake of intact γ-oryzanol by
cells was not detected after 2-hour incubation at 37oC. Longer incubation time was not studied
because the cells were vulnerable to the micellar solution, which was required to prepare γoryzanol in aqueous environment. However, the same cell model was also used to study
cholesterol uptake in vitro, and cholesterol uptake by cells was detected under the same
conditions. Additionally, when comparing the GC chromatograms of cell extracts after γ140
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Figure 5.9. Cytotoxicity study of γ-oryzanol micellar solution incubated
with human intestinal cells C2BBe1 at 37oC for 2 hours
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oryzanol uptake with those after the control (emulsion without γ-oryzanol) uptake, there were no
differences in detected compounds.
Compared to the Fujiwara study on the in situ intestinal absorption experiment, they
concluded that 89.4% of the dose was found in the luminal fluid 50 minutes after administration,
mostly as intact γ-oryzanol, and suggested that γ-oryzanol was poorly absorbed.
5.4 Conclusion
Digestibility of γ-oryzanol focusing on peptic and pancreatic digestions was studied. A
cell model using human intestinal cells in vitro was also developed to study whether or not γoryzanol uptake into cells occurred.
From all the information provided by this study, it may be implied that in the small
intestines, the ester bond of γ-oryzanol, especially campesteryl ferulate and sitosteryl ferulate,
was broken down by CEase and produced terpene alcohols or sterols and ferulic acid, both of
which may be further broken down since they were not found in the peptic and pancreatic
digestion products. Even though the degradation of γ-oryzanol, other than steryl ferulates, by
CEase was not as noticeable, they may be degraded by other substances in pancreatin since their
recoveries also decreased. The degradation of γ-oryzanol in the stomach may undergo a different
pathway because sterols or terpene alcohols were not found after peptic digestion. Moreover, γoryzanol in micellar solution was degraded more readily than in the crystalline form, proving
that micelle formation is necessary for lipid digestion in the gastrointestinal tract since the
surface area of dietary lipids in micelles increases and consequently the accessibility of the lipids
to the digestive enzymes in aqueous environment increases.
As for the γ-oryzanol uptake by human intestinal cells in vitro, intact γ-oryzanol uptake
by cells was not detected after 2-hour incubation. In this regard, relative to research that might be
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conducted in the future, identification of the digestion products, their cytotoxicity and uptake by
human intestinal cells are suggested in order to further understand the digestibility of γ-oryzanol.
Furthermore, there has been little information provided relative to biotransformation of γoryzanol and its digestion products by microflora in the human colon. This should also be
explored in the future since it has been a hot issue to develop functional foods to improve the
health of the human colon and to possibly protect against gut-related diseases.
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CHAPTER 6. CONCLUSION
In this study, in vitro cell models were developed and were used to study the
functionality, antioxidant activity and hypocholesterolemic capacity, and digestibility of γoryzanol. The cell lines chosen had a fast metabolism and consequently could be used to study
the functionality of γ-oryzanol in a relatively rapid manner. The general parameters that are
critical and vital when using cell models as tools for functionality experiments, are 1) the
emulsion preparation of hydrophobic compounds for cell models, 2) the consistent management
of cell culture, and 3) the selection of cell viability detection methods compatible with the cell
lines and the test substances.
An in vitro cell model using SVEC4-10 mouse lymph endothelial cells was established
and proven to be capable of distinguishing antioxidant activity of γ-oryzanol, ferulic acid, the
three major components of γ-oryzanol, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate
and campesteryl ferulate, as compared with α-tocopherol. tBHP was the oxidizing agent, whose
concentration and incubation time combinations were very critical, and the MTT assay was
chosen for cell viability determination because it had high response signals and did not interfere
with the test substances of interest. Four situations were designed to test whether or not the
compounds of interest might protect cells from tBHP oxidation, including 1) being
simultaneously present with tBHP and cells, 2) being associated with cells before tBHP
oxidation but not present with tBHP, 3) being associated with cells before and during tBHP
oxidation, and 4) interacting with tBHP before it reached cells. Generally, γ-oryzanol and ferulic
acid were found to possess antioxidant activity in terms of preventing cellular mitochondrial
damage due to tBHP oxidation. When γ-oryzanol or α-tocopherol was simultaneously present
with cells and tBHP, their antioxidant activity was not significant. When associated with the
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SVEC4-10 cells before tBHP oxidation, ferulic acid had higher antioxidant activity than γoryzanol and α-tocopherol at the early stage of oxidation (0 to 30 minutes) while γ-oryzanol and
α-tocopherol tended to have higher antioxidant activity than ferulic acid at the late stage of
oxidation (30 to 60 minutes). The three major components of γ-oryzanol generally had higher
antioxidant activity than γ-oryzanol and in the situation when associated with cells before and
during tBHP oxidation, they presented more powerful antioxidant activity than α-tocopherol.
Among these three major components of γ-oryzanol, 24-methylene cycloartanyl ferulate was
found to be relatively more effective. A synergistic antioxidant activity among γ-oryzanol,
ferulic acid and α-tocopherol was also found when simultaneously present with tBHP. Since the
quantity of γ-oryzanol in rice bran is much greater than vitamin E, γ-oryzanol may play a more
important role as an antioxidant to support the potential functional value of rice bran.
Regarding the hypocholesterolemic capacity of γ-oryzanol, this is the first time that the
possible mechanism for this γ-oryzanol function has been approached. This study postulated
relative to the aspects that γ-oryzanol may affect and then developed a model to investigate the γoryzanol effect from each aspect. An in vitro cell model using human intestinal cells (C2BBe1)
accompanied with GC/MS for cholesterol analysis was developed and used to detect cholesterol
uptake into cells in vitro. The results suggested that the intact γ-oryzanol was poorly absorbed by
intestinal cells, therefore, it was speculated that the effect of γ-oryzanol may take place in the
lumen of the gastrointestinal tract and the effect was on the availability of cholesterol for uptake
into cells. The results suggested activity from three standpoints. 1) γ-Oryzanol may affect the
availability of cholesteryl esters by reducing their micellar solubility because the uptake of
cholesteryl oleate was not found and the hydrolysis catalyzed by CEase to produce free

145

cholesterol was necessary. 2) Since the function of CEase to facilitate cholesterol uptake was not
found, γ-oryzanol may inhibit the hydrolytic function of CEase, which was essential for the
hydrolysis of cholesteryl esters and free cholesterol production. 3) Because it was found that
CEase and phospholipase A2 did not promote the uptake of free cholesterol, γ-oryzanol may
affect the availability of free cholesterol for uptake by decreasing its micellar solubility.
Digestibility of γ-oryzanol (in crystalline or in micellar solution) after peptic and
pancreatic digestions and the uptake of intact γ-oryzanol into cells were studied by an in vitro
cell model using human intestinal cells (C2BBe1). γ-Oryzanol was found to be degraded after
peptic and pancreatic digestions and the degree of degradation was higher in micellar solution
than in crystalline, proving that micelle formation is necessary for lipid digestion in the
gastrointestinal tract. The reasons may be relative to increased surface area of dietary lipids in
micelles and the consequence of increased accessibility of the lipids to the digestive enzymes in
aqueous environment. The effect of three pancreatic enzymes, CEase, lipase and phospholipase
A2, on γ-oryzanol degradation was further studied. The results showed that the ester bond of γoryzanol, especially campesteryl ferulate and sitosteryl ferulate, was broken down by CEase and
produced triterpene alcohols or sterols and ferulic acid. However, in the peptic and pancreatic
digestion products, triterpene alcohols or sterols and ferulic acid were not found and it may
suggest further degradation. The degradation of γ-oryzanol in the stomach may undergo a
different pathway because sterols or triterpene alcohols were not found after peptic digestion.
Additionally, the uptake of intact γ-oryzanol into cells was not detected, while cholesterol uptake
was, after 2-hour incubation.
Finally, more research is required in order to further understand the digestive and
metabolic fates of γ-oryzanol, including the degradation reactions, the identification of the
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digestion products, the toxicity and uptake of the digestion products into the human intestinal
cells, the functionality of the digestion products and interaction with the microflora in human
colon.
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APPENDIX I. SAS CODES
A. Antioxidant Activity
dm 'log;clear;output;clear;';
options ps=58 ls=98 nodate pageno=1;
data format1combo;
input day column type $ oxtime activity @@;
cards;
1 1 em 0 100.70 1 2 em 0 99.3 1 1 em 15
1 2 em 15 93.35 ...
5 1
f 30 56.6 5 2
f 30 76.6 5 1
f 45
5 2
f 45 68.1 5 1
f 60 39.2 5 2
f 60
run;
proc sort;
by day column type oxtime;
run;
proc mixed;
classes day column type oxtime;
model activity=type|oxtime/Ddfm=Satterth;
random day day*type column(day*oxtime);
lsmeans type|oxtime/diff;
run;
quit;

B. Cholesterol Uptake
dm 'log;clear;output;clear;';
options ps=58 ls=78 nodate pageno=1;
Data cholesteroluptake;
Input trial block trt $ sub uptake @@;
Cards;
1
1
Em
1
18.3745
1
1
C
1
15.7103
...
6
2
CO+ory+CEase
1
12.7126
6
2
CO+ory+CEase
2
14.0195
;
proc mixed;
classes trial block trt;
model uptake=trt/Ddfm=Satterth;
random trial block(trial) trt*block(trial);
lsmeans trt/diff;
run; quit;
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94.5
68.4
55.2;
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15
90.19 ± 3.19
88.46 ± 3.19
92.77 ± 3.19
92.34 ± 3.19
91.53 ± 3.91
95.16 ± 3.91
88.11 ± 3.91
92.16 ± 3.91

0
100.00 ± 2.88
100.00 ± 2.88
100.00 ± 2.88
100.00 ± 2.88
100.01 ± 3.79
100.01 ± 3.79
100.01 ± 3.79
100.01 ± 3.79

79.93 ± 2.88
78.07 ± 2.88
77.74 ± 2.88
80.40 ± 2.88
77.80 ± 3.79
82.58 ± 3.79
78.93 ± 3.79
74.70 ± 3.79

30
65.00 ± 2.88
67.89 ± 2.88
67.54 ± 2.88
62.24 ± 2.88
65.41 ± 3.79
60.66 ± 3.79
67.91 ± 3.79
69.84 ± 3.79

45

45.46 ± 2.88
47.63 ± 2.88
49.14 ± 2.88
46.49 ± 2.88
45.06 ± 3.79
44.08 ± 3.79
47.33 ± 3.79
54.81 ± 3.79

60

%cellular mitochondrial activity
control
0.5mM γ-oryzanol
0.5mM α-tocopherol
0.5mM ferulic acid
0.25mM γ-oryzanol+0.25mM α-tocopherol
0.25mM γ-oryzanol+0.25mM ferulic acid
0.25mM α-tocopherol+0.25mM ferulic acid
0.2mM γ-oryzanol+0.2mM α-tocopherol+0.2mM ferulic acid

for 0 to 60 minutes at 37oC (n=2 × 8 replications).
15
81.06 ± 6.11
90.78 ± 7.96
88.55 ± 6.13
97.82 ± 6.13
93.16 ± 7.96
98.23 ± 7.96
95.46 ± 7.96
90.08 ± 7.96

0
97.15 ± 5.10
97.31 ± 5.64
97.48 ± 5.12
95.83 ± 5.12
96.91 ± 5.64
96.97 ± 5.64
96.34 ± 5.64
97.14 ± 5.64

80.26 ± 6.11
92.76 ± 7.96
87.63 ± 6.13
94.47 ± 6.13
84.99 ± 7.96
87.91 ± 7.96
91.54 ± 7.96
87.37 ± 7.96

30

63.52 ± 6.11
80.01 ± 7.96
79.61 ± 6.13
73.78 ± 6.13
73.39 ± 7.96
69.06 ± 7.96
74.39 ± 7.96
74.61 ± 7.96

45

incubation time (min)
61.23 ± 4.17
62.41 ± 4.53
64.48 ± 4.31
52.21 ± 4.31
65.68 ± 4.53
61.84 ± 4.53
62.70 ± 4.53
60.16 ± 4.53

60

(b) Format 2: Cells were preincubated with each test solution for 22 hours at 37oC. Cells were then washed and incubated with tBHP

%cellular mitochondrial activity
control
1mM γ-oryzanol
1mM α-tocopherol
0.6mM ferulic acid
0.5mM γ-oryzanol+0.5mM α-tocopherol
0.5mM γ-oryzanol+0.3mM ferulic acid
0.5mM α-tocopherol+0.3mM ferulic acid
0.33mM γ-oryzanol+0.33mM α-tocopherol+0.2mM ferulic acid

incubation time (min)

(a) Format 1: SVEC4-10 cells were incubated with each test solution and tBHP for 0 to 60 minutes at 37oC (n=2 × 5 replications).
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100.00 ± 8.84
100.00 ± 8.84
100.00 ± 8.84
100.00 ± 8.84

0
75.73 ± 8.84
94.63 ± 8.84
93.80 ± 8.84
107.53 ± 8.84

15
67.08 ± 8.84
88.15 ± 8.84
89.25 ± 8.84
94.88 ± 8.84

30

incubation time (min)

54.73 ± 8.84
78.90 ± 8.84
83.10 ± 8.84
72.75 ± 8.84

45
54.50 ± 8.84
81.80 ± 8.84
74.63 ± 8.84
59.13 ± 8.84

60

%cellular
mitochondrial activity
control
1mM γ-oryzanol
1mM α-tocopherol
0.6mM ferulic acid
97.11 ± 5.57
96.48 ± 5.59
99.02 ± 5.62
100.76 ± 5.59

0
80.51 ± 6.63
81.78 ± 6.57
84.21 ± 6.57
84.49 ± 6.65

15

71.63 ± 6.55
69.83 ± 6.57
72.28 ± 6.57
74.40 ± 6.64

30

incubation time (min)

mixture for 0 to 60 minutes at 37oC (n=2 × 8 replications).

57.28 ± 6.55
56.83 ± 6.57
68.11 ± 6.57
64.02 ± 6.57

45

33.30 ± 4.70
34.10 ± 4.76
38.94 ± 4.75
32.00 ± 4.75

60

(d) Format 4: Each test solution was preincubated with tBHP in vials for 22 hours at 37oC and then cells were incubated with each

%cellular
mitochondrial activity
control
0.5mM γ-oryzanol
0.5mM α-tocopherol
0.5mM ferulic acid

(n=2 × 2 replications).

(c) Format 3: Cells were preincubated with each test solution for 22 hours at 37oC and then with tBHP for 0 to 60 minutes at 37oC
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%cellular mitochondrial activity
control
0.5mM γ-oryzanol
0.5mM α-tocopherol
0.5mM ferulic acid
0.25mM γ-oryzanol+0.25mM α-tocopherol
0.25mM γ-oryzanol+0.25mM ferulic acid
0.25mM α-tocopherol+0.25mM ferulic acid
0.2mM γ-oryzanol+0.2mM α-tocopherol+0.2mM ferulic acid
0.5mM cycloartenyl ferulate
0.5mM 24-methylene cycloartanyl ferulate
0.5mM campesteryl ferulate
61.73 ± 5.88

0
58.21 ± 6.34
65.52 ± 6.26
65.63 ± 6.26
65.12 ± 6.34
61.01 ± 6.34
64.37 ± 6.34
64.11 ± 6.34
64.28 ± 6.39
59.54 ± 6.39
59.29 ± 6.39

0.05
61.09 ± 6.34
66.32 ± 6.26
64.24 ± 6.26
66.17 ± 6.34
61.35 ± 6.34
64.07 ± 6.34
65.16 ± 6.34
63.43 ± 6.39
59.52 ± 6.39
60.51 ± 6.39

0.1

concentration (mM)

62.04 ± 6.34
67.92 ± 6.26
64.59 ± 6.26
66.73 ± 6.34
61.15 ± 6.34
64.29 ± 6.34
63.78 ± 6.34
65.62 ± 6.39
63.32 ± 6.39
61.76 ± 6.39

0.25

62.90 ± 6.05
64.66 ± 5.91
52.39 ± 5.26
66.17 ± 6.05
62.34 ± 6.05
64.02 ± 6.05
60.65 ± 6.05
63.82 ± 6.13
68.29 ± 6.13
62.77 ± 6.13

0.5

(e) Format 2 with each test solution at different dilutions including the three major components of γ-oryzanol. tBHP oxidation was 60
minutes at 37oC (n=2 × 8 replications).

APPENDIX III. DATA OF CHOLESTEROL UPTAKE EXPERIMENTS
(a) Effect of γ-oryzanol on micellar solubility of cholesterol and cholesteryl oleate
(n=2 × 2 replications).
%recovery of cholesterol, cholesteryl oleate or oryzanol in supernatant
cholesterol + ethanol
cholesterol + oryzanol
cholesteryl oleate + ethanol
cholesteryl oleate + oryzanol
oryzanol + control emulsion
oryzanol + cholesterol
oryzanol + cholesteryl oleate

100.00 ± 9.52
91.50 ± 9.52
100.00 ± 9.52
86.08 ± 9.52
100.00 ± 0.50
16.78 ± 0.50
4.82 ± 0.50

(b) Effect of γ-oryzanol preincubated with cholesterol for 0, 1, 2 or 6 hours on cholesterol uptake
into human intestinal cells in vitro, 2 hour, 37oC. (n=2×3 replications).
cholesterol uptake (µmol cholesterol/mg cell protein)
cholesterol
preincubation of cholesterol for 6 hours
cholesterol + oryzanol
preincubation of cholesterol + oryzanol for 1 hour
preincubation of cholesterol + oryzanol for 2 hours
preincubation of cholesterol + oryzanol for 6 hours
control emulsion

18.52 ± 3.82
16.77 ± 3.61
17.82 ± 2.65
17.33 ± 3.18
16.16 ± 2.77
14.05 ± 3.02
15.58 ± 2.36

(c) Effect of γ-oryzanol preincubated with cholesteryl oleate for 0 or 1hour before cholesterol
esterase-facilitated hydrolysis on cholesterol uptake into human intestinal cells in vitro, 2
hour, 37oC. (n=2×3 replications).
cholesterol uptake (µmol cholesterol/mg cell protein)
cholesterol
cholesteryl oleate + CEase
cholesteryl oleate + oryzanol + CEase
preincubation of (cholesteryl oleate) for 1 hour + CEase
preincubation of (cholesteryl oleate + oryzanol) for 1 hour + CEase
cholesteryl oleate
control emulsion
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18.52 ± 3.82
18.97 ± 2.51
16.01 ± 2.77
19.14 ± 3.18
14.89 ± 3.18
16.81 ± 2.37
15.58 ± 2.36
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